TW201213805A - Lysis buffers for extracting nucleic acids - Google Patents

Lysis buffers for extracting nucleic acids Download PDF

Info

Publication number
TW201213805A
TW201213805A TW99131421A TW99131421A TW201213805A TW 201213805 A TW201213805 A TW 201213805A TW 99131421 A TW99131421 A TW 99131421A TW 99131421 A TW99131421 A TW 99131421A TW 201213805 A TW201213805 A TW 201213805A
Authority
TW
Taiwan
Prior art keywords
nucleic acid
following
sample
adhesive
kit
Prior art date
Application number
TW99131421A
Other languages
Chinese (zh)
Inventor
James Stray
Yingjie Jason Liu
Maxim Brevnov
Jaiprakash Shewale
Allison Holt
Original Assignee
Life Technologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Technologies Corp filed Critical Life Technologies Corp
Priority to TW99131421A priority Critical patent/TW201213805A/en
Publication of TW201213805A publication Critical patent/TW201213805A/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present teachings relate to the extraction of nucleic acid from solid materials. Provided are useful compositions, methods and kits for obtaining nucleic acids from a solid biological sample or an adhesive material having a biological material adherent or embedded within the adhesive substrate. The extracted nucleic acid can be used in downstream applications such as genotyping, detection, quantification, and identification of the source of the biological material.

Description

201213805 六、發明說明: 【發明所屬之技術領域】 [0001]本申請案主張於2009年9月16日申請之美國臨時專利申請 案第61,243,136號、2010年6月30日申請之美國臨時專 利申請案第61,360, 386號以及2010年9月1日申請之美 國臨時專利申請案第61,379,346说之優先權。申請宰號 、流水號第 10/306, 347、11/789, 352以及60/334, 029 號,為任何目的將其全部内容於此併入以作為參考。201213805 VI. Description of the Invention: [Technical Fields of the Invention] [0001] This application claims the application of the U.S. Provisional Patent Application No. 61,243,136, filed on Sep. 16, 2009, on June 30, 2010. The priority of U.S. Provisional Patent Application No. 61,360,386, and U.S. Provisional Patent Application No. 61,379,346, filed on Sep. 1, 2010. Application Serial No. 10/306, 347, 11/789, 352, and No. 60/334, 029, the entire disclosure of which is incorporated herein by reference.

[0002] 〇 099131421 一般來說,本教示係相關於從固態材料例如骨、齒和詞 化組織或從嵌入或附著於黏著性材料或粗斜紋布材料之 生物性樣本中萃取核酸。 【先前技術】 從固體生物材料例如化之骨與齒或包含丧入及/或附著 於黏著性與含膠材料之核酸的生物樣本,以及於乾燥或 嵌於粗斜紋布材料之生物材料中萃取核酸存在著處理樣 本的挑戰以及在法醫實驗室中處理樣本的可能延遲性。 法醫樣本、失蹤者、古代以及降解的樣本亦具有可能伴 隨沖提的核酸而萃取出的PCR抑制劑而更加複雜。本教示 提供了有用組合物及方法’以從固態生物樣本、具有生 物材料附著物或嵌於附著的受質或粗斜紋布材料或土壤 之黏著性材料中獲取核酸(例如基因體DNA以及rna)。所 萃取之核酸可被用於下游的應用例如(基因分型、偵測、 定量以及生物材料的來源鑑定),其中使用例如pcR之分 子生物步驟。所提供之裂解溶液可被用以製備高數量之 核酸(例如DNA),以及保留萃取自妈化組織或於踢及/戋 黏著性受質與材料以及粗斜紋布受質與材料之生物組織 表單编號A0101 第3頁/共54頁 ^ 1003014903-0 201213805 的^ADNA。此溶液提供用於萃取羅的高效率方法以 及用於移除PCR抑制劑之方法,以及排除pCR抑制劑萃取 之方法。此外’用於萃取和純化核酸的程序為全自動的( 使用標準液體處理系統)。 本文中所使用的章節標題僅作為組織之目的,以及不能 以任何方式被解釋為限制所描述之標的物。所有本說明 書中被引述的文獻包括但不限於,專利、專利說明書、 技術文件、書藉,以及論文係為任何目的將其全部内容 於此併入以作為參考。當任何併入之文獻與任何本文所 定義之用語相矛盾時,以本說明書為準。當本教示連結 许多具體實施例而描述時,不意圖將本教示限制於此類 具體實施例中。相反地,本教示包括許多替代方案、修 飾以及相同物,如同那些本領域之技術人員將領會的。 [0003] 【發明内容】 [0004] 在一些具體實施例中’揭露内容係用用於裂解具有附著 物或嵌於生物材料中之固體。具有組合物之裂解試劑溶 液具有清潔劑、螫合劑、還原劑以及酵素的其中之一或 更多。清潔劑可為陰離子清潔劑、離子性清潔劑或其結 合物。該清潔劑可為N-月桂肌胺酸(NLS,也被稱為月桂 醯肌胺酸納(Sarc〇sy 丨或5〇心1!11118111'〇71531'(;03-i n a t e ))、去乳膽酸納,C T A B,十二基y? - D -麥芽糖甘 ,壬醒基_N-甲基麵酿胺,聚乙二醇對-(1,1,3,3-四曱 基丁基)-苯基醚,十二烧基硫酸鈉(SDS)以及其結合物 的其中之〆或更多。螫合劑可為四醋酸乙二醇(EGT A ) 099131421 表單編號A0101 第4頁/共54頁 1003014903-0 201213805 與四醋酸乙二胺(edta)、檸檬酸以及其結合物的其中 之一或更多。還原劑可為三(2_羧乙基)膦(TCEP)、二 硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)的其中之一或 更多。酵素可為半胱天冬酶、胰凝乳蛋白酶、胃蛋白酶 、蛋白酶κ、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴蛋白酶 、木瓜酶、芽孢桿菌sp· E1A蛋白酶以及胰蛋白酶的其中 之-或更多。鹽類可為氣化納、氣化卸、氣化錢、氣化 猛以及其氣化與峨化的形式的其中之一或更多。此裂解 0 溶液可具有範圍由5.0 ' 12.0,或5.1、6.0、7.0、 8. 0 9. 〇 ' 1 〇. G碎11. 〇以及在每―整數中之區間起之 pH值。 在一些具體實施例中,經由裂解溶夜而裂解之固態樣本 具有核酸。此固禮可為生物材料、黏著性受質或天然或 β成的X質。在-些具體實施例中,生物材料可為骨、 軟骨,帶、肌腱以及牙齒。在—些具體實施例中,黏 著性材料可為口香糖、雪祐屁股、於蒂、屬著薄膜、黏 〇 練藏、貼、紙、皮膚貼咐物、信封、信封封口、郵旱(例 如郵資郵票)與膠帶。在一些具體實施例中’生物性樣本 可嵌入或附著於黏著性的材料。 在許多具體實施例中’皮膚貼附物係選自電子電極、可 轉移的圖騰、皮膚滲透之化學物質貼片與傷口照護敷料 所組成之群組。並且,膠帶可為黏著繃帶、運_帶、 包裝膠帶、輸送管磁帶、電I膠帶、頭髮膠帶、指紋膠 帶剝離以及諸如此類。 在-些具體實施例中’所揭露者為使用所揭露的裂解溶 1003014903-0 液以製造包含核酸之產物的方法。此方法包括在裂解溶 099131421 表單編號Α0101 第5頁/共54頁 201213805 液中培養固態樣本,並且萃取由固態樣本中萃取出之核 酸所在的上清液。此固態樣本可為例如骨、軟骨、勤帶 肌腱以及牙齒之生物材料、例如口香糖、雪莊屁股、 終蒂、黏著薄膜、黏著標籤、貼紙、皮膚貼附物、信封 、信封封口、郵票、指紋膠帶剝離以及膠帶之黏著性材 料、粗斜紋布材料。在一些具體實施例中,此方法亦可 i括當培養混合物時,將在裂解溶液中之固態樣本搖動 及/或渦旋、在培養後將在裂解溶液中之固態樣本離心、 將在裂解溶液中之生物性樣本、生物材料及/或固態樣本 裂解,以生成具有核酸之裂解液並萃取裂解液,以獲得 帶有核酸之產物。 在其他具體實施例中,所揭露者為從固體中分離核酸的 方法,其中固體係經由裂解溶液裂解並且將裂解液離心 ,以從仍然在上清液的核酸中將固體分離。在一些具體 實施例中,此方法亦可包括搖晃伴隨裂解溶液之固體, 並萃取裂解液以獲得伴隨自固體令分離的核酸之產物。 在其他具體實施例中,使用本文所描述之方法將核酸從 指紋膠帶剝離上移除可用於鑑定有機物,生物材料從該 有機物得到。此核酸可用於針對STR、HLA標記與RFLp 刀i、Υ-STR與Υ-SNP分型、mtDNA定序以及插入/刪除 夕型性分型之基因分型試驗。指紋與基因分型試驗結合 或分隔而可用於對指紋收集及/或指紋資料庫進行比較, 以作為鑑定之目的。 其他具體實施例包括用於從例如具有上皮細胞、血液、 精液唾液或其他為本領域之技術人員所知的生物性體 099131421 液之生物材料、黏著性材料或受質以及粗斜紋布材料或 表單編號A0101 第6頁/共54頁 1003014903-0 201213805 受質之固體中萃取核酸的套組。此套組具有第一清潔劑 、螫合劑、還原劑以及酵素的其中之一而作為每一者的 分離溶液或結合。在一些具體實施例中,此套組亦可具 有隨選的溶液例如具有聚合物之溶液。此聚合物包含葡 聚醣、纖維素、纖維素衍生物、可溶性澱粉、糊精、纖 維糊精、聚乙二醇、肝素、肝醣以及其結合物的其中之 一或更多。此套組亦可具有第二清潔劑、清洗溶液、第 二清洗溶液、無D N a s e之水、磁性裝置以及可被磁性吸引 % 的顆粒(包含葡聚醣包裹的磁性奈米顆粒)。應了解所 提供的具體實施例不需具有所有本文所描述之方面和特 徵。應了解這些方面與具體實施例僅為本發明之示範與 解解釋性的,並且不為限制性的。 申請者提供作為由包含微小核酸量的樣本中萃取核酸方 法之具體實施。此類方法之具體實施例為快速的、免於 使用有機溶劑、步驟簡化的以及伴隨改善使用者安全性 而降低樣本處理與交叉汙染的風險》 > 本教示的這些以及其他特徵於本文提出。 【實施方式】 [0005] 作為解譯此說明書之目的,將採用下列定義並當合適時 ,以單數使用的用語將亦包括複數並且反之亦然。當下 文提出的任何定義與在其他文件(包括併入於本文作為參 考的任何文件)中那個字的用法相衝突時,除非清楚意指 相反的意義(例如在用語原本使用的文件中),總以下 文所提出的定義為準而作為解譯此說明書與其相關申請 專利範圍的目的。應注意的是,如同使用於此說明書與 附屬的申請專利範圍,除非明確地與沒有歧義地限制於 099131421 表單編號 A0101 第 7 頁/共 54 頁 1003014903-0 201213805 -所指物’單數形式「- (a)」、「一(an)」與「此 (the )」包括複數之所指示物。除非另外指明,使用「 或」意指「及/或」。為說明之目的但非作為限制,「χ 及/或Y」可意指「X」或Γγ」或者Γχ」與「γ」。使用 「包含(comprise)」、「包含(c⑽prises)」、「 包含(comprising)」、「包括(include)」、「包 括(includes)」與「包括(inciuding)」為可相互 替換的並且非意圖為限制。此外,若一或更多具體實驗 例的描述使用此用語「包含」,那些本領域之技術人員 將了解在一些特定的範例中,此具體實施例(emb〇di_ raent)或具體實施例(emb〇dim.e.nts)可使用「主要由 …組成(consisting essentially of )」及/或「由 …組成(consisting 〇f )」的語言而替代地描述。此 用語「及/或」意指一或所有列舉的元素或任何二或更多 列舉之元素。 本發明的實行可採取傳統的技術以及在本領域技術範圍 内之有機化學、聚合物技術、分子生物學(包括重組技 術)、細胞生物定、生物袍學以及免疫學之描述。此類 傳統技術包括募核普酸合成、雜交作用、延伸反應以及 使用標記偵測雜交作用。適合的技術之特定說明可經由 參考本文下述之範例而取得。然而,其他同等的傳統程 度當然也可以使用。此類傳統技術和描述可被發現於標 準實驗室手冊,例如Genome Analysis: A Laboratory Manual Series (Vols. I—IV)、 PGR Primer: A Laboratory Manual 以及Molecular Cloning: A Laboratory Manual (全部皆來自 Cold Spring Har- 099131421 表單編號A0101 第8頁/共54頁 1003014903-0 201213805 bor Laboratory Press, 1 989 ) 'Gait, w〇ligo- nucleotide Synthesis: A Practical Approach” 1984 、 IRL Press, London, Nelson與Cox (2000)、[0002] 〇 099131421 In general, the teachings relate to the extraction of nucleic acids from solid materials such as bone, teeth and lexical tissue or from biological samples embedded or attached to an adhesive material or denim material. [Prior Art] Extraction of nucleic acids from solid biological materials such as bones and teeth or biological samples containing nucleic acids that are afflicted and/or attached to adhesive and gel-containing materials, and biological materials that are dried or embedded in denim materials There are challenges in processing samples and possible delays in processing samples in forensic laboratories. Forensic samples, missing persons, ancient and degraded samples are also more complex with PCR inhibitors that may be extracted with the extracted nucleic acids. The present teachings provide useful compositions and methods' to obtain nucleic acids (e.g., genomic DNA and rna) from solid biological samples, adhesives having biomaterial attachments or embedded in adherent or denim materials or soil. The extracted nucleic acid can be used for downstream applications such as (genomic typing, detection, quantification, and identification of sources of biological material) using molecular biological steps such as pcR. The lysing solution provided can be used to prepare high amounts of nucleic acids (eg, DNA), as well as biological tissue forms that are extracted from the masculinized tissue or in the knit and/or adhesive adherents and materials as well as denim substrates and materials. No. A0101 Page 3 of 54 ^ 1003014903-0 201213805 ^ADNA. This solution provides a highly efficient method for extracting argon and methods for removing PCR inhibitors, as well as methods for excluding pCR inhibitor extraction. In addition, the procedure for extracting and purifying nucleic acids is fully automated (using standard liquid handling systems). The section headings used herein are for organizational purposes only and are not to be construed as limiting the subject matter described. All documents cited in this specification include, but are not limited to, patents, patent specifications, technical documents, books, and papers, which are hereby incorporated by reference in its entirety for all purposes. In the event of any inconsistency between any incorporated document and any term defined herein, the present specification controls. The present teachings are not intended to be limited to such specific embodiments when the present teachings are described in connection with the specific embodiments. Rather, the teachings include many alternatives, modifications, and equivalents, as will be appreciated by those skilled in the art. SUMMARY OF THE INVENTION [0004] In some embodiments, the disclosure is directed to cracking a solid having an attachment or embedded in a biological material. The lysing reagent solution having the composition has one or more of a detergent, a chelating agent, a reducing agent, and an enzyme. The detergent may be an anionic detergent, an ionic detergent or a combination thereof. The detergent may be N-lauric myosinic acid (NLS, also known as laurel sarcosine sodium (Sarc〇sy 丨 or 5〇心1!11118111'〇71531' (;03-inate)), de-milking Sodium cholate, CTAB, Twelfth y?-D-maltose, 壬 基 _N-methyl melamine, polyethylene glycol p-(1,1,3,3-tetradecylbutyl) -Phenyl ether, sodium dodecyl sulfate (SDS) and combinations thereof, or more. The chelating agent may be ethylene glycol tetraacetate (EGT A ) 099131421 Form No. A0101 Page 4 of 54 1003014903-0 201213805 One or more of ethylenediamine tetraacetate (edta), citric acid and combinations thereof. The reducing agent may be tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE) and one or more of dithiothreitol (DTT). The enzymes may be caspase, chymotrypsin, pepsin, protease kappa, thrombin, Staphylococcus V8 protease, chain Among them - or more of mold protease, papain, Bacillus sp. E1A protease and trypsin. Salts can be gasification, gasification, gasification, gasification and gasification. One or more of the deuterated forms. This cleavage 0 solution can have a range from 5.0 '12.0, or 5.1, 6.0, 7.0, 8. 0 9. 〇' 1 〇. G smashed 11. 〇 and in every ― The pH in the interval between the integers. In some embodiments, the solid sample that is cleaved by lysis nightly has a nucleic acid. This can be a biological material, an adhesive substrate, or a natural or beta-forming X. In some embodiments, the biological material may be bone, cartilage, band, tendon, and teeth. In some embodiments, the adhesive material may be chewing gum, snow, buttocks, pedicle, film, and adhesive. Tibetans, stickers, paper, smudges, envelopes, envelopes, postage (such as postage stamps) and tape. In some embodiments, 'biological samples can be embedded or adhered to adhesive materials. In many implementations In the example, the skin patch is selected from the group consisting of an electronic electrode, a transferable totem, a skin infiltrated chemical patch, and a wound care dressing, and the adhesive tape can be an adhesive bandage, a tape, a packaging tape, Duct tape, I tape, hair tape, fingerprint tape peeling, and the like. In the specific embodiments, the method disclosed is the use of the disclosed lysing solution 1003014903-0 liquid to produce a product comprising a nucleic acid. The method includes the lysing solution 099131421 Form No. Α0101 Page 5 of 54201213805 A solid sample is cultured in a liquid, and the supernatant of the nucleic acid extracted from the solid sample is extracted. The solid sample may be, for example, bone, cartilage, tendon, and teeth. Materials such as chewing gum, snowy buttocks, finishing pedicles, adhesive films, adhesive labels, stickers, skin patches, envelopes, envelope seals, stamps, peeling of fingerprint tapes, adhesive materials for tapes, denim materials. In some embodiments, the method may also include shaking and/or vortexing the solid sample in the lysis solution when the mixture is cultured, centrifuging the solid sample in the lysis solution after culturing, and lysing the solution in the lysis solution. The biological sample, the biological material, and/or the solid sample are cleaved to generate a lysate having the nucleic acid and extract the lysate to obtain a product carrying the nucleic acid. In other specific embodiments, the disclosed method is a method of isolating nucleic acids from a solid, wherein the solids are cleaved via a lysis solution and the lysate is centrifuged to separate the solids from the nucleic acid still in the supernatant. In some embodiments, the method can also include shaking the solids accompanying the lysis solution and extracting the lysate to obtain a product accompanying the nucleic acid isolated from the solids. In other embodiments, the removal of nucleic acid from the fingerprint tape using the methods described herein can be used to identify an organic material from which the biological material is derived. This nucleic acid can be used for genotyping assays for STR, HLA markers and RFLp cutter i, Υ-STR and Υ-SNP typing, mtDNA sequencing, and insertion/deletion sigmoid typing. Fingerprints can be used in conjunction with genotyping tests to separate fingerprint collection and/or fingerprint databases for identification purposes. Other specific embodiments include biomaterials, adhesive materials or substrates, and denim materials or form numbers for use, for example, from epithelial cells, blood, semen saliva, or other biologically known 099131421 fluids known to those skilled in the art. A0101 Page 6 of 54 1003014903-0 201213805 Kit for extracting nucleic acids from a solid. This kit has one of a first detergent, a chelating agent, a reducing agent, and an enzyme as a separate solution or combination for each. In some embodiments, the kit may also have an optional solution such as a solution having a polymer. The polymer comprises one or more of dextran, cellulose, cellulose derivatives, soluble starch, dextrin, cell dextrins, polyethylene glycol, heparin, glycogen, and combinations thereof. The kit may also have a second cleaning agent, a cleaning solution, a second cleaning solution, water without D N a s e , a magnetic device, and particles that are magnetically attracted to % (magnetic nanoparticles coated with dextran). It will be appreciated that the specific embodiments provided are not required to have all of the aspects and features described herein. It should be understood that these aspects and specific embodiments are merely illustrative and illustrative and not restrictive. The applicant provides a specific implementation as a method of extracting nucleic acids from a sample containing a small amount of nucleic acid. Specific embodiments of such methods are rapid, free from the use of organic solvents, simplified steps, and reduced risk of sample handling and cross-contamination with improved user safety. > These and other features of the present teachings are set forth herein. [Embodiment] The following definitions are used for the purpose of interpreting this specification and, where appropriate, the terms used in the singular will also include the plural and vice versa. When any definitions set forth below conflict with the usage of that word in other documents (including any documents incorporated herein by reference), unless clearly stated to the contrary (eg, in the document originally used), The definitions set forth below are intended to serve the purpose of interpreting this specification and its related claims. It should be noted that, as used in this specification and the appended claims, unless explicitly and unambiguously limited to 099131421 Form No. A0101 Page 7 of 54 Page 301014903-0 201213805 - Refers to the 'singular form' - (a), "an" and "the" include the plurals. Unless otherwise stated, the use of "or" means "and/or". For the purposes of illustration and not limitation, "χ and / or Y" may mean "X" or Γγ" or Γχ" and "γ". Use "comprise", "include (c(10)prises), "comprising", "include", "includes" and "inciuding" as mutually replaceable and non-intentional For the limit. In addition, if the description of one or more specific experimental examples uses the term "comprising", those skilled in the art will appreciate that in some specific examples, this particular embodiment (emb〇di_ raent) or specific embodiment (emb) 〇dim.e.nts) may be alternatively described using a language consisting of "consisting essentially of" and/or "consisting 〇f". The term "and/or" means one or all of the listed elements or any two or more recited elements. The practice of the present invention can be carried out using conventional techniques as well as descriptions of organic chemistry, polymer technology, molecular biology (including recombinant techniques), cell biology, biological robes, and immunology within the skill of the art. Such traditional techniques include nucleoside acid synthesis, hybridization, extension reactions, and the use of markers to detect hybridization. Specific descriptions of suitable techniques can be obtained by reference to the examples described herein below. However, other equivalent traditional degrees can of course be used. Such traditional techniques and descriptions can be found in standard laboratory manuals such as Genome Analysis: A Laboratory Manual Series (Vols. I-IV), PGR Primer: A Laboratory Manual, and Molecular Cloning: A Laboratory Manual (all from Cold Spring) Har- 099131421 Form No. A0101 Page 8 of 54 1003014903-0 201213805 bor Laboratory Press, 1 989 ) 'Gait, w〇ligo-nucleotide Synthesis: A Practical Approach” 1984, IRL Press, London, Nelson and Cox (2000) ),

Lehninger, Principles of Biochemistry 3rdEd.,W. H. Freeman Pub., New York N.Y.以及 Berg et al. (2002) Biochemistry, 5thEd., W. H. Freeman Pub.,New York,N.Y。為了所有目的, 其全部皆以全文併入本文作為參考。 Ο 如同本文中所使用的,該用語「附著」意指介於至少兩 物體或表面之間的轉命,或者至少兩物體或表面結合在 一起。此黏合可為至少兩物體或表面的共同融合、黏合 或黏貼。 如同本文中所使用的,該用語「黏著劑(adhesive)」 意指能夠結合至少兩物體之物質。黏著劑可為水泥、膠Lehninger, Principles of Biochemistry 3rdEd., W. H. Freeman Pub., New York N.Y. and Berg et al. (2002) Biochemistry, 5th Ed., W. H. Freeman Pub., New York, N.Y. All of the objects are hereby incorporated by reference in their entirety for all purposes.如同 As used herein, the term "attached" means a transition between at least two objects or surfaces, or at least two objects or surfaces joined together. This bond can be a common fusion, bonding or pasting of at least two objects or surfaces. As used herein, the term "adhesive" means a substance that is capable of binding at least two objects. Adhesive can be cement, glue

水、漿糊、搬粉、膠或化學化合物或來自天然或合成之 來源的聚合物’並且可應用於作為兩物禮之一的信封、 膜、標籤、紙、贴片、郵票或膠帶。黏著劑可為液體或 固體或經由蒸發或加熱、紫外光固化或其他物理性途徑 以乾燥而生成固體。第一物體可具有其不可缺的黏著劑( 例如膠)或對其施用的黏著劑(例如膠帶)。替代地,此第 一物體包含黏著劑,以使第一物體能相應於其所形成的 鍵結而以可移除的、暫時的、半持續的或持續的狀態來 與至少第二物體結合。黏著劑可經由例如唾液之液體施 用而製造為可溶或具黏性的。舉例來說,郵票在其用於 仏封之刖經由舌頭添拭的時候。另一個範例可為信封封 099131421 口,其在被躁拭的時候是使得信封封口上之黏著劑變為 表單編號A0101 第9頁/共54頁 1003014903-0 201213805 八I〖生的,並且接著在折疊起以閉合信封開口的時候, 由於黏著劑維持信封封口持續的、幾乎永久的信封接觸 而產生密封。 如同本文中所使用的,該用語「黏著性材料(遞“⑽ material)」以及「黏著受質(adhesive )」交替使用,並且意指的物體包含或具有其組合物不 可缺的黏著劑、具黏性的表面或黏著組合物,例如口香 糖、雪茄屁股、菸蒂、黏著薄膜、黏著標籤、貼紙、皮 膚貼附物、信封封口、郵票、用於剝離指紋之膠帶、生 物的、有機或無機的材料以及膠帶。 如同本文中所使用的’該用語「黏著薄膜(adhesive f 」意指可附著於物體上之薄而具彈性的片狀物。 此膜可持續附著於物體上或為可移除的。 如同本文中所使用的,該用語「黏著標籤(adhesive label)」或「黏著標籤(a(jhesive sticker)」意指 的物體具有辨識資訊或設計:於上表面而能經由與辨識資 訊或设計相對的表面而附著於'另f一物邊或表面上。此標 籤可持續附著於其他物體或為寸移徐的。 如同本文中所使用的,該用語「貼紙(adhesive paper )」意指伴隨黏著表面的紙(纖維素、木漿衍生的、乙 烯、塑料或合成紙),該黏合表面相應於其所附著的表 面而形成可移除的、暫時的、半永久或永久的黏合,例 如信封、郵票、可重覆黏著固體或具黏性之便條或貼紙 〇 如同本文中所使用的,該用語「皮膚貼附物(adhes i ve skin patch)」意指能以可移除的形式附著至完整或受 099131421 表單編號A0101 第10頁/共54頁 1003014903-0 201213805 損(傷害)的皮膚表面之圓形、橢圓形、長方形或其他 形狀物例如EKG電極、可轉移圖騰、尼古丁貼片以及石膏 〇 如同本文中所使用的,該用語「膠帶(adhesive tape )」意指可附著於另一物體或表面上之具彈性的帶或帶 狀物,例如運動膠帶、包裝膠帶、Scotch®品牌膠帶。 此膠帶可永久地附著於其他物體或表面上或為可移除的 。此膠帶在水溶液或有機溶液中可為可溶的或不溶的。 如同本文中所使用的,該用語「生物材料」意指血液、 黏液、精液、唾液、皮膚組織、骨、軟骨、韌帶、肌腱 、牙齒、指紋等。生物材料可為生物來源之約化的、硬 化的、固態以及天然的組合物。生物材料可具有包含核 酸之固體、流體、組織或細胞。生物材料可包括但不限 於核酸,該核酸包含自黏著及/或具黏性材料回收之材料 ,該黏著及/或具黏性材料包括但不限於口香糖、雪茄屁 股、菸蒂、黏著薄膜、黏著標籤、貼紙、皮膚貼附物、 信封、信封封口、郵票、指紋膠帶剝離以及膠帶。 如同本文中所使用的,該用語「生物性樣本」意指附著 或欲入於黏著性材料中的生物材料,如:血液、黏液、 精液、唾液、皮膚細胞、皮膚組織、骨、軟骨、韌帶、 肌腱、齒、流體、組織或細胞。此生物性樣本包含核酸 〇 如同本文中所使用的,「DNA」意指如同本領域所了解之 其各種形式的去氧核糖核酸,例如基因體DNA、cDNA、分 離之核酸分子、質體DNA以及染色體DNA。「核酸」意指 任何形式的核酸分子(molecule)或分子(molecules 099131421 表單編號A0101 第11頁/共54頁 1003014903-0 201213805 )、DNA或RNA (核糖核酸)。如同本文中所使用的,該 用語「核酸分子」或「被萃取之核酸」意指已經由其天 然環境中回收之核酸分子(任何形式之DNA或RNA)。被 萃取之核酸分子的一些例子為部分或大體上被純化之核 酸分子、由法醫和包含生物材料的其他樣本獲得之核酸 ,該生物材料例如企液、黏液、精液、唾液、皮膚組織 、骨、軟骨、韌帶、肌腱與齒等等。亦設想的是自黏著 及/或具黏性材料回收之生物材料,其包括但不限於口香 糖、雪茄屁股、菸蒂、黏著薄膜、黏著標籤、貼紙、皮 膚貼附物、信封、郵票與膠帶,以及經由法醫、犯罪、 研究、搜尋與救援以及回收方法與技術而收集之源於考 古、刑事現場處理、法醫、人類鑑定、天然和大規模災 難現場之核酸樣本。 如同本文中所使用的,該用語「指紋」和「指紋圖像」 於本文交替地使用,並意指指狀物腹面表面上發現皮膚 表皮之脊和凹陷處的時候製造的皮膚之脊的壓痕摩擦, 該指狀物包括但不限於手指和腳趾、拇指以及手掌和單 一腳掌接觸表面。 如同本文中所使用的,該用語「基因體DNA」所指核酸包 含基因的染色體DNA序列或基因的片段,其包括DNA序列 的非編碼區以及編碼區。基因體D N A也意指由生物性樣本 (如:骨、齒、組織、細胞或染色體或無性繁殖之拷貝的 全部或部分此類MA)中直接分離之DNA。基因體MA亦指 由黏著及/或具黏性之材料(如:口香糖、雪茄屁股、菸 蒂、黏著薄膜、黏著標籤、貼紙、皮膚貼附物、信封、 郵票與膠帶)所萃取之DNA。膠可為天然或合成之來源。 099131421 表單編號A0101 第12頁/共54頁 1003014903-0 201213805 天然膠可為乳膠、阿拉轉、膠豆膠奇科勝與奇科膠 (hicle and Chicle varieties)例如契科與橡 膠樹(chic〇0 and chic〇zap〇te)。合成膠可為聚里 烯。 ’、 如同本文十所使用的,該用語「粗斜紋布材料」以及「 粗斜紋布”」係交替使用並^意指動物或植物來源之 任者的材料。粗斜紋布材料完全由棉或棉混紡天然或 。成纖維所組成。棉質粗斜紋布料可包括但不限於藍色Water, paste, powder, glue or chemical compounds or polymers from natural or synthetic sources' can be applied to envelopes, films, labels, paper, patches, stamps or tapes as one of the two objects. The adhesive can be a liquid or solid or can be solidified by evaporation or heat, UV curing or other physical means to dry. The first object may have its indispensable adhesive (e.g., glue) or an adhesive (e.g., tape) to which it is applied. Alternatively, the first object comprises an adhesive to enable the first object to engage at least the second object in a removable, temporary, semi-continuous or continuous state corresponding to the bond formed thereby. The adhesive can be made soluble or viscous via the application of a liquid such as saliva. For example, a stamp is added to the tongue after it is used for sealing. Another example can be an envelope seal 099131421 mouth, which when wiped is made the adhesive on the envelope seal into the form number A0101 page 9 / total page 54 1003014903-0 201213805 eight I〗, and then When folded to close the opening of the envelope, the seal is created as the adhesive maintains a continuous, almost permanent envelope contact of the envelope seal. As used herein, the terms "adhesive material" and "adhesive" are used interchangeably and mean that the object contains or has an adhesive that is indispensable to its composition. Adhesive surface or adhesive composition, such as chewing gum, cigar butt, cigarette butts, adhesive film, adhesive labels, stickers, skin patches, envelope seals, stamps, tapes used to peel fingerprints, biological, organic or inorganic materials And tape. As used herein, the term "adhesive f" means a thin, elastic sheet that can be attached to an object. The film can be attached to an object or can be removed. As used herein, the term "adhesive label" or "a (jhesive sticker)" means an object that has identification information or design: on the upper surface, as opposed to identifying information or design. The surface is attached to the 'other side' or the surface. This label can be attached to other objects or moved in. As used herein, the term "adhesive paper" means the accompanying adhesive surface. Paper (cellulose, wood pulp derived, vinyl, plastic or synthetic paper) that forms a removable, temporary, semi-permanent or permanent bond corresponding to the surface to which it is attached, such as envelopes, stamps, Refillable solid or viscous note or sticker 〇 As used herein, the term "adhes i ve skin patch" means attached to a removable form Integrity or subject to 099131421 Form No. A0101 Page 10 / Total 54 Page 1003014903-0 201213805 Round, oval, rectangular or other shapes of the skin surface of damage (injury) such as EKG electrodes, transferable totems, nicotine patches and plaster As used herein, the term "adhesive tape" means a flexible band or ribbon that can be attached to another object or surface, such as sports tape, packaging tape, Scotch® brand tape. The tape may be permanently attached to other objects or surfaces or may be removable. The tape may be soluble or insoluble in an aqueous or organic solution. As used herein, the term "biological material" means Refers to blood, mucus, semen, saliva, skin tissue, bone, cartilage, ligaments, tendons, teeth, fingerprints, etc. Biomaterials can be biologically derived, hardened, solid, and natural compositions. A solid, fluid, tissue, or cell comprising a nucleic acid. The biological material can include, but is not limited to, a nucleic acid comprising self-adhesive and/or viscous Material to be recycled, including but not limited to chewing gum, cigar butt, cigarette butts, adhesive film, adhesive labels, stickers, skin patches, envelopes, envelope seals, stamps, fingerprint tape peeling and tape As used herein, the term "biological sample" means a biological material that is attached or intended to be incorporated into an adhesive material, such as blood, mucus, semen, saliva, skin cells, skin tissue, bone, cartilage, Ligament, tendon, tooth, fluid, tissue or cell. This biological sample contains nucleic acid. As used herein, "DNA" means various forms of DNA, such as genomic DNA, as is known in the art. , cDNA, isolated nucleic acid molecules, plastid DNA, and chromosomal DNA. "Nucleic acid" means any form of nucleic acid molecule or molecule (molecules 099131421 Form No. A0101 Page 11 of 54 1003014903-0 201213805), DNA or RNA (ribonucleic acid). As used herein, the term "nucleic acid molecule" or "extracted nucleic acid" means a nucleic acid molecule (DNA or RNA of any form) that has been recovered from its natural environment. Some examples of extracted nucleic acid molecules are partially or substantially purified nucleic acid molecules, nucleic acids obtained by forensic and other samples containing biological materials, such as liquid, mucus, semen, saliva, skin tissue, bone, Cartilage, ligaments, tendons and teeth, etc. Also conceived are biomaterials that are self-adhesive and/or viscous material recovery, including but not limited to chewing gum, cigar butt, cigarette butts, adhesive films, adhesive labels, stickers, skin patches, envelopes, stamps and tapes, and Nucleic acid samples from archaeological, criminal field processing, forensic, human identification, natural and large-scale disaster sites collected through forensics, crime, research, search and rescue, and recycling methods and techniques. As used herein, the terms "fingerprint" and "fingerprint image" are used interchangeably herein and refer to the pressure of the ridge of the skin that is created when the ridges and depressions of the skin epidermis are found on the ventral surface of the finger. Trace friction, including but not limited to fingers and toes, thumb and palm and single sole contact surfaces. As used herein, the term "genetic DNA" refers to a nucleic acid comprising a chromosomal DNA sequence of a gene or a fragment of a gene comprising a non-coding region of a DNA sequence and a coding region. The gene D N A also means DNA that is directly isolated from a biological sample (eg, all or part of such a MA of bone, tooth, tissue, cell or chromosome or a copy of vegetative reproduction). Genome MA also refers to DNA extracted from adherent and/or viscous materials such as chewing gum, cigar butt, cigarette butts, adhesive films, adhesive labels, stickers, skin patches, envelopes, stamps and tapes. The gum can be a natural or synthetic source. 099131421 Form No. A0101 Page 12 of 54 1003014903-0 201213805 Natural rubber can be latex, Ala, Gicle and Chicle varieties such as Chico and Rubber Tree (chic〇0 and Chic〇zap〇te). The synthetic gum can be a polyene. As used herein, the terms "rough twill material" and "thick twill" are used interchangeably and refer to materials of any animal or plant origin. The denim material is completely blended with cotton or cotton natural or. Made up of fiber. Cotton denim fabric may include, but is not limited to, blue

暗藍色、黑色、石洗、酸洗以及諸如此類。 如同本文中所使用的’該用語「多核苷酸」、「寡核苷 酸」以及「核酸」在本文中交替地使用,.並意指核苷 酸單體的單股和雙股聚合物,她而:不關於2,-去氧核 糖核酸(DNA)以及核糖核酸(RNA) ’其經由核苦酸/ 的磷酸二鍵或核㈣内的類似物以及相關的相反離子( 如11 NH4、二烧基敍、Mg2+、Na+等等)而連繫。多核苦 酸可完全由去氧核糖核㈣、.完h核糖姆酸或其喪Dark blue, black, stone wash, pickled, and the like. As used herein, the terms "polynucleotide", "oligonucleotide" and "nucleic acid" are used interchangeably herein, and mean single-stranded and double-stranded polymers of nucleomonomers, She does: not about 2,-deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) 'its its interaction via nucleotides of phosphoric acid/nucleic acid (4) and related counterions (eg 11 NH4, II) Connected to the base, Mg2+, Na+, etc.). Polynucleic acid can be completely depleted by ribonucleoside (IV), h-ribose or its fungus

s物而組成’並可包括核苷酸的類似物。核势酸單 體單元可包含任何核㈣或核聽類似物。多㈣酸业 型的範園大小是從數個單體單元(如5_40 (雖然有時它們 在本領域指為隸聽)至數千個單體核㈣單元。除 非另外表示’每當表示多核料列,將了解的是,核皆 酸為由左至右是5,至3,的順序,並且「A」表示去氧腺普 酸、「C」代表去氧Μ酸、「G」代表去氧^酸、「τ 」代表去氧_«以及「U」代表去氧科酸,除非另 外指明。 099131421 第13頁/共54頁 如同本文巾所❹的,該用語「固體」意指麵體的材 表單編號Α0101 « ι〇 --1003014903-0 201213805 料,例如黏著劑,其包含材料以及具有基質之硬化的、 緻密的材料,例如妈化的生物材料,如:骨、齒,以及 軟骨、肌腱和韌帶以及由脫落的皮膚細胞組成的常見粉 末。此固體可包含或移似包含核酸。 如同本文中所使用的,該用語「固體樣本」意指堅硬、 緻密的材料,可能為生物材料,例如骨、軟骨、勃帶、 肌腱與齒或無孔以及/或不溶於水的黏著性材料,並且包 含或疑似包含核酸。 在此同時,數字範圍的列舉以及端點上的數字範圍包括 在該在範圍以内納入的所有數字(例如1至5包括1、1. 5 、2、2. 75、3、3. 80、4、5等等)。 在本教示中之一些具體實施例中,組合物、方法和套組 的描述中,可將核酸分子分離及/或由樣本中萃取,並且 在一些具體實施例中,其此組合物、方法和套組所製造 之產物為核酸。在一些具體實施例中,本教示的組合物 、方法和套組造成包含萃取之核酸的產物生成。 在本教示中之一些具體實施例中提供組合物,其中樣本 可伴隨包含至少一清潔劑、螫合劑、還原劑和酵素以及 其結合物的每一裂解溶液而被處理,以從此樣本中萃取 核酸分子。在各種具體實施例中,樣本可包含一或更多 游離的核酸;從固體基質中萃取包括但不限於生物材料 ,例如骨、軟骨、韌帶、肌腱與齒等等。在各種具體實 施例中,樣本可包含由黏著性材料所萃取之核酸,其包 括但不限於例如口香糖、雪茄屁股、菸蒂、黏著薄膜、 黏著標籤、貼紙、皮膚貼附物、信封封口、郵票、指紋 膠帶剝離和膠帶之材料。在一些具體實施例中,樣本可 099131421 表單編號A0101 第14頁/共54頁 1003014903-0 201213805 包含由粗斜紋布材料萃取之核酸,Α ,、匕括但不限於 藍色、暗藍色、黑色、石洗、酸洗以 括 久諸如此類之刼叔 紋布料。在本教示額外的具體實施 斜 本文所描诚士办 酸可從樣本中萃取的方法,包含將樣本伴隨包含核 多清潔劑、螫合劑、還原劑、鹽類和酵素之或更 並且萃取上清液的步驟。培養可以是在室w 。養 ^ 5 C、j π C、41°C、42°C、43°C、44-C、45。(:、5frr 〇u L、51。c、 52〇C ' 53〇C ' 54〇C ' 55〇C ' 56〇C ^ 57°r 7 C、5»°C、59 Ο t町、心與WC,以及其中的區間。此方法可 進-步包含將培養的溶㈣心以自上驗移除固體,以 及處理上清液以分離核酸的步驟&s constitutes ' and can include analogs of nucleotides. The nuclear acid monomer unit may comprise any core (4) or nuclear hearing analog. The size of the poly(tetra) acid type is from a number of monomeric units (such as 5-40 (although they are sometimes referred to in the art) to thousands of monomeric cores (quad). Unless otherwise indicated, 'each time indicates a multicore. In the list, it will be understood that the nuclear acid is from 5 to 3 in order from left to right, and "A" represents deoxyadenosine, "C" represents deoxyacid, and "G" represents Oxygenic acid, "τ" stands for deoxygenated_« and "U" stands for deoxycortic acid, unless otherwise indicated. 099131421 Page 13 of 54 This article is used in this article, the term "solid" means the facet The material form number Α0101 « ι〇--1003014903-0 201213805 materials, such as adhesives, which contain materials and hardened, dense materials with matrix, such as maternal biological materials such as: bone, teeth, and cartilage, Tendons and ligaments and common powders composed of exfoliated skin cells. This solid may contain or migrate to contain nucleic acids. As used herein, the term "solid sample" means a hard, dense material, possibly a biological material, Such as bone, cartilage, ribbon, tendon Adhesive material with or without pores and/or insoluble in water, and containing or suspected of containing nucleic acids. At the same time, the enumeration of numerical ranges and the numerical ranges on the endpoints include all numbers that are included within the range (eg 1 to 5 include 1, 1.5, 2, 2. 75, 3, 3. 80, 4, 5, etc.) In some embodiments of the present teachings, in the description of the compositions, methods and kits The nucleic acid molecules can be isolated and/or extracted from the sample, and in some embodiments, the products made by the compositions, methods, and kits are nucleic acids. In some embodiments, the compositions of the present teachings , methods and kits result in the production of a product comprising the extracted nucleic acid. Compositions are provided in some embodiments of the present teachings, wherein the sample may be accompanied by at least one detergent, chelating agent, reducing agent and enzyme, and combinations thereof. Each lysis solution is treated to extract nucleic acid molecules from the sample. In various embodiments, the sample may comprise one or more free nucleic acids; extraction from the solid substrate includes, but is not limited to, organisms Materials such as bone, cartilage, ligaments, tendons and teeth, etc. In various embodiments, the sample may comprise nucleic acids extracted from an adhesive material including, but not limited to, for example, chewing gum, cigar butt, butt, adhesive film, Adhesive labels, stickers, skin patches, envelope seals, stamps, fingerprint tape peeling and tape materials. In some embodiments, the sample can be 099131421 Form No. A0101 Page 14 / Total 54 Page 1003014903-0 201213805 Contains The nucleic acid extracted from the twill material, Α, 匕, but not limited to blue, dark blue, black, stone washed, pickled to cover such a long uncle of the cloth. In this teaching, the additional implementation is described in this article. A method by which an acid can be extracted from a sample, comprising the step of accommodating the sample with a nuclear multi-cleaner, a chelating agent, a reducing agent, a salt and an enzyme, or extracting a supernatant. Cultivation can be in the room w. Raise 5 C, j π C, 41 ° C, 42 ° C, 43 ° C, 44-C, 45. (:, 5frr 〇u L, 51.c, 52〇C ' 53〇C ' 54〇C ' 55〇C ' 56〇C ^ 57°r 7 C, 5»°C, 59 Ο t town, heart and WC, and the interval therein. This method may further comprise the steps of removing the solid from the cultured solution and removing the nucleic acid from the supernatant, and the step of treating the supernatant to separate the nucleic acid &

G 由此獲得的核酸可接著使用於任何各種下游的應用和八 析,例如,舉例來說,特定核酸或甚至生物物種的定量 、偵測和基因分型。舉例來說,這些分析可經由pcR擴增 作用而進行。舉一個例子,在法醫DNA分析中,人類核 DNA (nDNA)及/或基因體DNA能由複雜的生物材料獲得 ,然後使用PCR以基因分型。舉另一個例子,]qNa製備可 用於定量人類DNA(或更具體地,男性人類DNA),其使用 例如Quantifiler®或Quantifiler Duo®套組(Ap_ plied Bi〇systems/Life Technologies C〇rp Foster City,CA)之即時聚合酶鏈鎖反應系统,以及 /或舉例來說,使用例如AmpFISTR®套組的系統,以針對 體染色體或Y染色體短串聯重複序列位點作基因分型。根 據存在於樣本中的DNA量,可選擇特定的基因分型系統, 以生成對於特定分析所需的最佳結果。因此,為了於下 游應用中最佳地使用核酸,特別需要萃取與分離方法不 099131421 表單編號A0101 1003014903-0 第15頁/共54頁 201213805 僅造成同產蓋的產物,也要相對地沒有下游應用(例如 PCR)的抑制劑之產物。經由定量、偵測以及基因分型而 分析之核酸可用於鏗定核酸的來源。 典塑地,法醫的證據樣本在樣本種類、受質或基質上為 具變兴的,其中生物材料為内嵌的,其包括但不限於, 固體生物性樣本或所收集之法醫樣本的表面,其可能造 成樣本暴露於環境的傷害,被pcR抑制劑的汙染以及限制 起始樣本材料。包含但不限於法醫的證據樣本的核酸萃 取(其經常暴露於溫度的變化、過量的濕度或脫水的情況 ’以及在取得過程中如同為本領域異一般技藝之技術人 員所知的樣本汗染物)可能導致在分離掻酸的困難以及潛 在的化合物汗染’例如:作用是抑觯pCR的粗斜紋布料的 其他化學處理而或染劑,並因此於基因分型或其他分析 時企圖干擾。改良萃取程序為需要的,並於這樣做時, 於分離核酸的期間移除抑制劑,例如用於法醫分析的DNA 或RNA(在使用於後續步驟之前採甩例如擴增之酵素)。 舉一個例子,法醫樣本可於樣本祕集時採用黏著性材料 或者是樣本本身的組成部分。黏著脅,丨的存在經常降低核 酸的整體回收,因為如同使用粒狀物分離核酸黏著劑 可能干擾分離的步驟。在例舉如下的範例中,顯示由菸 蒂、口香糖以及在膠帶剝離中之乾燥的血液、唾液和生 物材料(包括皮膚細胞和來自指紋的細胞)中萃取之核 酸導致較高的核酸回收以及當經由短串聯重複序列(str )分析以圖表描述時為沒有pCR汙染物。 困難的法醫樣本的另—個例子為固體生物材料,其包括 但不限於,鈣化的組織例如骨與齒。此緻密的基質需要 1003014903-0 099131421 表單編號A0101 第丨6頁/共^頁 201213805The nucleic acid thus obtained can then be used in any of a variety of downstream applications and assays, such as, for example, quantification, detection and genotyping of specific nucleic acids or even biological species. For example, these analyses can be performed via pcR amplification. As an example, in forensic DNA analysis, human nuclear DNA (nDNA) and/or genomic DNA can be obtained from complex biological materials and then genotyped using PCR. As another example, qNa preparation can be used to quantify human DNA (or more specifically, male human DNA) using, for example, the Quantifiler® or Quantifiler Duo® kit (Ap_plied Bi〇systems/Life Technologies C〇rp Foster City, The instant polymerase chain reaction system of CA), and/or, for example, uses a system such as the AmpFISTR® kit to genotype a short tandem repeat site for a somatic chromosome or a Y chromosome. Depending on the amount of DNA present in the sample, a particular genotyping system can be selected to generate the best results for a particular analysis. Therefore, in order to optimally use nucleic acids in downstream applications, extraction and separation methods are particularly required. 099131421 Form No. A0101 1003014903-0 Page 15 / Total 54 Pages 201213805 Only results in the production of the same cover, but also relatively no downstream applications The product of an inhibitor (e.g., PCR). Nucleic acids that are analyzed by quantification, detection, and genotyping can be used to determine the source of the nucleic acid. In a typical place, forensic evidence samples are subject to change in the type, substance or matrix of the sample, wherein the biological material is embedded, including but not limited to, solid biological samples or surfaces of forensic samples collected, It may cause damage to the sample from exposure to the environment, contamination by the PCR inhibitor, and restriction of the starting sample material. Nucleic acid extractions, including but not limited to forensic evidence samples, which are often exposed to changes in temperature, excessive humidity or dehydration, and sample perspiration as known to those skilled in the art in the course of acquisition. It may lead to difficulties in isolating tannic acid as well as potential compound sweating's, for example: other chemical treatments or dyes that act to suppress the denier of pCR, and thus attempt to interfere with genotyping or other assays. A modified extraction procedure is required, and in doing so, the inhibitor is removed during the isolation of the nucleic acid, such as DNA or RNA for forensic analysis (for example, an enzyme that is amplified prior to use in subsequent steps). As an example, a forensic sample can be used as an adhesive material or as part of the sample itself. Adhesion, the presence of ruthenium often reduces the overall recovery of nucleic acids, as the separation of nucleic acid adhesives using granules may interfere with the separation step. In an example exemplified below, nucleic acids extracted from cigarette butts, chewing gum, and dried blood, saliva, and biological materials (including skin cells and cells from fingerprints) in tape stripping result in higher nucleic acid recovery and when The short tandem repeat (str) analysis is depicted as a no pCR contaminant when depicted in the graph. Another example of a difficult forensic sample is a solid biomaterial including, but not limited to, calcified tissue such as bone and teeth. This dense substrate needs 1003014903-0 099131421 Form No. A0101 Page 6 / Total ^ Page 201213805

冗長、勞力密集的程序,在微量的椋酸萃取出之前經常 持續超過24小時。本揭露的教示係經由破壞鈣化基質而 達到最大量的DNA回收,而使此生物材料的大部分與裂解 試劑溶液接觸。來自骨和齒之樣本的1)題產量總結於表格 1。在例子中注意由骨和齒中萃取核酸需要的時間,達到 理想產量僅在兩小時之後。因為所揭露之裂解溶液組合 物以及作為萃取核酸的方法造成改善與更快速的DNA回收 ,存在於樣本的DNA之量可以更高靈敏度地經由為本領域 之技術人員所知的即時聚合酶鏈鎖反應之方法而偵測。 本教示的各種具體實施例係相關於有效率的萃取核酸, 例如,舉例來說,基因體DNA的數量使得:使用Prep-Filer™法醫ΜΑ萃取套組(P/N 4392852或4392353,The lengthy, labor-intensive process often lasts for more than 24 hours before the trace amount of citric acid is extracted. The teachings of the present disclosure achieve maximum amount of DNA recovery by disrupting the calcification matrix while contacting most of the biological material with the lysis reagent solution. The yield of 1) questions from bone and tooth samples is summarized in Table 1. In the example, note the time required to extract the nucleic acid from the bone and teeth to achieve the desired yield only after two hours. Because the disclosed lysing solution composition and the method of extracting nucleic acid result in improved and faster DNA recovery, the amount of DNA present in the sample can be more sensitively detected by an instant polymerase chain lock known to those skilled in the art. Detection by the method of reaction. Various embodiments of the present teachings relate to efficient extraction of nucleic acids, such as, for example, the amount of genomic DNA such that: the Prep-FilerTM forensic extraction kit is used (P/N 4392852 or 4392353,

Applied Biosystems,Foster City, CA)的隨後核 酸的分離和沖提提供了適合作為DNA定量與分析的核酸。 Ο 於是這些教示的具體實施例使核酸(例如基因體DNA)有 效率地萃取自各種固體種類的生物材料、包含黏著劑之 材料以及來自粗斜紋布之生物流體樣本。此外例如基因 體DNA的核酸可從一般於實驗室處理之小量或大量的生物 材料中被分離,例如,舉例來說,那些涉及基因分型分 析者。 本文提供的裂解溶液之具體實施例可包含例如四醋酸乙 二醇(EGTA)及/或四醋酸乙二胺(EDTA)及/或擰檬酸 之螫合劑的混合物(較佳地以250-500 mM為範圍);例 如至少一種之N-月桂肌胺酸、去氧膽酸鈉、CTAB、N_十 二基;5-D-麥芽糖甘、壬醯基-N-甲基麩醯胺、Triton® X-100、NP-40及/或十二烷基硫酸鈉之清潔劑(較佳地 099131421 表單編號A0101 第17頁/共54頁 1003014903-0 201213805 以0. 1%至3%為範圍);例如氯化鈉、氯化鉀、氯化鎂、 氣化錳以及其氟化與碘化的形式之鹽類(以50 mM至500 mM為範圍);以及例如三(2-羧乙基)膦(TCEP)、二硫 赤鮮醇(DTE)與二硫蘇糖醇(DTT)之還原劑(較佳地 以1 0至1 0 0 mM為範圍),以及例如至少一種半胱天冬酶 、胰凝乳蛋白酶、胃蛋白酶、蛋白酶K、凝血酶、葡萄球 菌屬V 8蛋白酶、鏈黴蛋白酶、木瓜酶、芽孢桿菌s_ p. E1A 蛋白酶以及胰蛋白酶的酵素(較佳地以0.5至1 mg/mL為 範圍)。下面提供的表格指出萃取效率,以作為在裂解 溶液的各種培養時間、起始固體的量和種類、黏著性或 粗斜紋布材料之比較。裂解溶液將核酸從固體基質或黏 著性材料中萃取出,以使得核酸上清液可被分離並使用 Pr epF i 1 er711套組清洗不純物。 本教示的這些具體實施例與其他特徵由本文的描述將變 為更顯著。 本教示的各種具體實施例係相關於裂解溶液和使用此溶 液的方法(其可經檢驗而裝配於套組中),其用於由含有 生物性樣本與例如生物性樣本(被認為包含或已知含有核 酸)的固體樣本之黏著性材料萃取核酸,該核酸包括但不 限於基因體DNA。黏著性材料可為例如經由法醫的方法而 收集之膠帶剝離,如乾燥的血液、唾液和指紋,以及信 封封口、郵票,其包括但不限於,郵票、贈券、狩獵證 郵票、保護郵票、口香糖、雪茄屁股、菸蒂、黏著薄膜 、黏著標籤、貼紙、皮膚貼附物、信封、郵票與膠帶以 及此類。黏著性材料被認為包含附著或嵌入黏著性材料 中之核酸,並且本教示係相關於由黏著性材料樣本中萃 099131421 表單編號A0101 第18頁/共54頁 1003014903-0 201213805 取核酸,若存在的話。黏著性材料已顯示當使用卜叩一 Filer™套組時,會干擾後續核酸分離純化和整體產量 。黏著劑在prepFiler計晝書生成之聚合物—核酸〜磁Z 顆粒複合物中會干擾磁性顆粒的操作。此複合物的生成 是使得聚合物讓核酸陷入,聚合物附著於磁性顆粒並 且如此間接地將磁性顆粒連結到核酸,直到複合物被清 洗以移除汙染物與抑制劑’如此核酸為可修正的使用於 下游的應用,例如PCR ^在本文所教示之裂解溶液的發展 之前,從包含樣本的黏著劑中獲得核酸為困難、繁瑣與 低產量的。 如在製造時所使用粗斜紋布料(包括但不限於,藍色牛仔 褲、裙子和夾克)中所發現染劑、色素和纖維會抑制從該 處所分離之核酸在基因分型試驗的STR分析’例如Iden-tifiler® 套組(Applied Biosystems)。纖維似乎 與色素或染劑複合並在PrepFiler計畫書生成之聚合物-核酸-磁性顆粒複合物中干擾磁性顆粒的操作。這使得從 粗斜紋布樣本所獲得的核酸受到PCR抑制劑的損害,在本 文所教示之Tris-Cl裂解溶液的發展之前,回收DNA為困 難、繁瑣和低產量的。 本教示的各種具體實施例係相關於例如用於基因體DNA的 核酸萃取,包含用於從固體生物性樣本與黏著劑中萃取 核酸之裂解溶液、方法和套組,該固體生物性樣本包括 但不限於’骨、軟骨、韌帶、肌腱與齒。這些方法的具 體實施例可包含:以溫和的清潔劑溶液清潔固體樣本、 風乾隔夜、以磨光石移除外層,並丘將樣本粉碎。將製 備的樣本接著伴隨裂解溶液培養,以使包含核酸的細胞 099131421 表單編號A0101 第19頁/共54頁 1003014903-0 201213805 從固體基質中釋放。此固體生物材料包含核酸,並且本 教示係相關於由固體材料萃取核酸。鈣化和硬化的生物 材料已顯示當使用PrepFi ler™套組(Appl ied Biosystems,Foster City,CA)時’提供低產量的 核酸,因為固體基質對核酸的萃取和分離提供了特殊挑 戰。來自固體生物材料之核酸產量已經在PrepFi ler計 畫書之前使用本文教示的裂解溶液而改進。 標準的核酸分離技術包括(細胞裂解以及核酸的清洗和沖 提)為本領域所熟知,並且除非另外指明,其可根據的各 種技術舉例來說是描述歡浦A Typing Protocols: Molecular B ίο logy and Forensic Analysis, lstedition, B. Budowleet ai..eds., Eaton Publishing Co. (2000) ; JM But 1er,ForensicThe subsequent isolation and elution of the nucleic acid by Applied Biosystems, Foster City, CA provides nucleic acids suitable for quantification and analysis of DNA. Thus, specific embodiments of these teachings enable the efficient extraction of nucleic acids (e.g., genomic DNA) from various solid species of biological materials, materials containing adhesives, and biological fluid samples from denim. In addition, nucleic acids such as genomic DNA can be isolated from small amounts or large amounts of biological material that is typically processed in the laboratory, such as, for example, those involved in genotyping. Specific examples of the lysis solution provided herein may comprise a mixture of, for example, tetraacetic acid glycol (EGTA) and/or ethylene tetraacetate (EDTA) and/or citric acid chelating agents (preferably 250-500). mM is a range); for example, at least one of N-lauric acid, sodium deoxycholate, CTAB, N-dodecylate; 5-D-maltosine, thiol-N-methyl branamide, Triton ® X-100, NP-40 and/or sodium lauryl sulfate detergent (preferably 099131421 Form No. A0101 Page 17 of 54 page 1003014903-0 201213805 with a range of 0.1% to 3%) Such as sodium chloride, potassium chloride, magnesium chloride, manganeseated gas and salts thereof in the form of fluorinated and iodinated (in the range of 50 mM to 500 mM); and, for example, tris(2-carboxyethyl)phosphine ( TCEP), a reducing agent of dithioerythritol (DTE) and dithiothreitol (DTT) (preferably in the range of 10 to 100 mM), and, for example, at least one caspase, pancreas Chymotrypsin, pepsin, proteinase K, thrombin, Staphylococcus V 8 protease, pronase, papain, Bacillus sp. p. E1A protease and trypsin Hormone (preferably 0.5 to 1 mg / mL of the range). The table provided below indicates the extraction efficiency as a comparison of the various incubation times of the lysis solution, the amount and type of starting solids, the adhesion or the denim material. The lysis solution extracts the nucleic acid from the solid substrate or adhesive material so that the nucleic acid supernatant can be separated and the impurities are washed using the Pr epF i i er711 kit. These specific embodiments and other features of the present teachings will become more apparent from the description herein. Various embodiments of the present teachings relate to a lysis solution and a method of using such a solution (which can be assembled into a kit by inspection) for use in containing biological samples and, for example, biological samples (considered to contain or have been The adhesive material of the solid sample containing the nucleic acid is extracted, and the nucleic acid includes, but is not limited to, genomic DNA. Adhesive materials can be stripped, for example, by forensic methods, such as dry blood, saliva, and fingerprints, as well as envelope closures, stamps including, but not limited to, stamps, coupons, hunting license stamps, protective stamps, chewing gum. , cigar butt, cigarette butts, adhesive films, adhesive labels, stickers, skin patches, envelopes, stamps and tapes, and more. Adhesive materials are considered to contain nucleic acids attached or embedded in an adhesive material, and the teachings are related to the extraction of nucleic acids from a sample of adhesive material 099131421 Form No. A0101 Page 18 of 54 1003014903-0 201213805, if any . Adhesive materials have been shown to interfere with subsequent nucleic acid isolation and overall yield when using the Bulk-FilerTM kit. Adhesives interfere with the operation of magnetic particles in the polymer-nucleic acid to magnetic Z particle composites produced by the prepFiler. The formation of this complex is such that the polymer traps the nucleic acid, the polymer attaches to the magnetic particles and thus indirectly binds the magnetic particles to the nucleic acid until the complex is washed to remove contaminants and inhibitors such that the nucleic acid is correctable For downstream applications, such as PCR, obtaining nucleic acids from an adhesive containing a sample is difficult, cumbersome, and low-yielding prior to the development of the lysis solution taught herein. Dyes, pigments, and fibers found in denim fabrics (including, but not limited to, blue jeans, skirts, and jackets) used in manufacturing inhibit the STR analysis of the nucleic acid isolated from the genotyping test in the genotyping test' Iden-tifiler® kit (Applied Biosystems). The fibers appear to complex with pigments or dyes and interfere with the operation of the magnetic particles in the polymer-nucleic acid-magnetic particle composites produced by the PrepFiler program. This results in damage to the nucleic acid obtained from the denim sample by PCR inhibitors, which are difficult, cumbersome, and low-yielding prior to the development of the Tris-Cl lysis solution taught herein. Various embodiments of the present teachings relate to, for example, nucleic acid extraction for genomic DNA, including lysis solutions, methods and kits for extracting nucleic acids from solid biological samples and adhesives, including Not limited to 'bone, cartilage, ligaments, tendons and teeth. Specific embodiments of these methods can include: cleaning the solid sample with a mild detergent solution, air drying overnight, removing the outer layer with a matte stone, and smashing the sample with the mound. The prepared sample is then incubated with the lysis solution to release the nucleic acid containing cells 099131421 Form No. A0101 Page 19 of 54 1003014903-0 201213805 from the solid substrate. This solid biological material contains nucleic acids, and the teachings are related to the extraction of nucleic acids from solid materials. Calcified and hardened biomaterials have been shown to provide low yield nucleic acids when using the PrepFilerTM kit (Appl ied Biosystems, Foster City, CA) because solid matrices offer particular challenges for nucleic acid extraction and separation. Nucleic acid production from solid biomaterials has been improved prior to the PrepFiler program using the lysis solution taught herein. Standard nucleic acid isolation techniques, including (cell lysis and washing and rinsing of nucleic acids), are well known in the art and, unless otherwise indicated, may be described by various techniques, for example, by describing A Typing Protocols: Molecular B ίοlogy and Forensic Analysis, lstedition, B. Budowleet ai..eds., Eaton Publishing Co. (2000) ; JM But 1er, Forensic

DNA Typing: Biology, Technology, and Genetics of STR Markers,2ndedition, Elsevier Aca-demic Press (2005);或者P. Giil,"Application of Low Copy Number DNA Profiling," Croatian Medical Journal42 : 229^-232 (2001 ) ; FRDNA Typing: Biology, Technology, and Genetics of STR Markers, 2ndedition, Elsevier Aca-demic Press (2005); or P. Giil, "Application of Low Copy Number DNA Profiling," Croatian Medical Journal42 : 229^-232 ( 2001 ) ; FR

Bieberet ai·,"Isolation of DNA from Forensic Evidence,"Current Protocols in H u m a n G e n e t- ICS, Supplement 26 (2000) ; Forensic DNA Pro filing Protocols, Metiiucls in Molecular Bio logy, vo1. 9 8, PJ Lincoln and J. Thomson, eds., Humana Press (1998)° 申請者已發現當針對包含核酸的黏著性材料與固體生物 性樣本使用PrepFiler的計畫書,經由使用本文所教示 099131421 表單編號A0101 第20頁/共54頁 1003014903-0 201213805 的具有一或更多清潔劑、螫合劑、還原劑、鹽類和酵素 之裂解試劑溶液,核酸可更容易地分離和純化。裂解溶 液改進了來自黏著性材料、固體生物樣本的核酸(例如基 因體DNA)的產量與效率。清潔劑可為極性或非極性的。 適合的清潔劑的一些例子包括但不限於N-月桂肌胺酸( NLS)、月桂醯肌胺酸(也被稱為月桂醯肌胺酸(sar-cosyl)),一種衍生自肌胺酸的離子界面活性劑;十六 基三甲基漠化兹(hexadecyltr i methyl ammonium bromide或cetyltrimethylammonium bromide, CTAB);去氧膽酸;檸檬酸鈉;去氧膽酸鈉;十二基/3-D-麥芽糖甘;壬醯基-N-甲基麩醯胺;十二烷基硫酸鈉; 聚乙二醇p-(l,1, 3, 3-四甲基丁基)-苯基醚(一般稱為 Triton®X-100 );以及其結合物。在一些具體實施例中 ,清潔劑包含0.5至3% w/v之範圍的NLS。適合的螫合劑 的一些例子包括但不限於,約250至750 mM的範圍之四 醋酸乙二胺(EDTA)、乙二醇雙(2-胺基乙基)-Ν,Ν,Ν’ ,Ν’ -四醋酸(EGTA)與擰檬酸。適合的還原劑的一些例 子包括但不限於,約10至100 mM的範圍之三(2-羧乙基) 膦(TCEP)、二硫赤鮮醇(DTE)與二硫蘇糖醇(DTT) (在使用前新鮮配製)。適合的酵素的一些例子包括但不 限於,在裂解溶液中的最後濃度範圍0.5至10 mg/ml的 半胱天冬酶、胰凝乳蛋白酶、胃蛋白酶、蛋白酶K、凝企 酶、葡萄球菌屬V8蛋白酶、鏈黴蛋白酶、木瓜酶、芽孢 桿菌sp. E1A蛋白酶以及胰蛋白酶。在一些具體實施例中 ,裂解溶液在使用前經由與螫合劑結合、於pH約7. 5至 8. 5下伴隨清潔劑與鹽類,接著加入還原劑溶液與酵素而 099131421 表單編號A0101 第21頁/共54頁 1003014903-0 201213805 製備。 在一些具體實施例中,螫合劑係於具有清潔劑、帶有或 不帶鹽類之溶液中製備,還原劑為新鮮製備的,以及酵 素係於'谷液中。鹽類為在溶液中或存在於清潔劑溶液中 。接著洛液可在使用之前合併以形成裂解溶液。替代地 ,在本教示的—些具體實施例中,裂解溶液可被製備然 後/東乾。λ;東乾的裂解試劑可於使用前再被溶解。此類 束乾的方法為傳統的並為本領域具—純藝之技術人員 所知新鮮製備的裂解溶液的結果為組成分未降解或氧 匕例如發生疋因可存在於長期的存放或暴露於光線下 且因而降健酸萃取和核酸的總產量》在-些具體實施 例中將黏著性材料或固體生物材料在由約至 下培養兩小時,以從黏著性材料中釋放細胞的物質或 疋固體生物性基質是56〇c為普遍使用的溫度。在一些具 體實施例巾,天然或合成材料係於自約4G mo。(:培養 40刀鐘至1小蚪。此萃取可經由搖晃來協助。在一些具體 實施例中,裂解溶液進一步包含保護释出核酸的化合物 並且維持它們在下游試驗的相容性,例如,舉例來說, PCR試驗以及在特定的DNA基因分型系統,舉例來說str 試驗。 在將黏著性材料或固體生物性樣本培養之後,可將樣本 離心,以粒狀化殘餘固體組織或黏著性材料。此生成的 上清液產物包含核酸。此上清液適合用於核酸分離與純 化(使用為本領域具一般技藝之技術人員所知的方法或商 業的核1为離與純化產品,例如pr epF i 1 e r TM套組)。此 套組可使用以移除細胞碎片、殘餘汙染物及/或pCR抑制 099131421 表單編號A0101 第22頁/共54頁 1003014903-0 201213805 劑。 在本教示中之一些具體實施例中,接著,核酸分子可從 固體基質中被分離’其包括但不限於:骨;軟骨;動帶 •’肌腱;以及齒。在一些具體實施例中,生物性樣本為 鈣化、乾縮、烘乾或不然是天然或防腐的狀態。在一些 具體實施例中’固體生物性樣本係被分散、粉碎、研磨 或用其他方式磨成細緻顆粒(例如粉末)。核酸(例如D N a ) 的產量’依固體材料的年齡、起始材料的量以及樣本的 q 降解或保存而變化。來自骨和齒樣本之核酸(如DNA)的產 置總結於表格1 〇 來自100 mg長骨樣本的MA產量範圍是自(L25至2.15 ng ’其對於此類樣本種類為典型的,因為每一骨樣本獨 特在生物性樣本的内含物與狀態。針對内部PCR控制組( IPC)之、數值係經由Quantifiler®人類DNA定量套組 (Applied Biosystems)而測定,相較於無模板控制 組(NTC,表格1 )之數值,該(^數值針對所測試的骨樣 q 本無顯著增加。若DNA萃取物包含PCR抑制劑,典型地, 相較於NTC的IPC (^值,將預期有樣本(^數值之上移( Applied Biosystems,Quantifiler®人類DNA定量套 組以及Quantifiler®Y雄性人類DNA定量套組。使用者手 冊。PN 4344790 Rev. B,(2003))。因此,存在於 骨和齒樣本中的PCR抑制劑在DNA萃取期間已有效率地移 除(使用裂解試劑溶液,接著以PrepFiler™套組試劑分 離和純化)。 099131421 表單編號A0101 第23頁/共54頁 1003014903-0 201213805 表格1 :來自骨與齒的人類DNA產量 樣本a 描述 總產量 (ng) IPCCT 數値 骨-1 100 mg長骨 1.9 27.05 骨-2 100 mg長骨 0.66 27.12 骨-3 100 mg長骨 1.19 26.96 骨-4 100 mg長骨 1.6 27.19 骨-5 100 mg長骨 0.8 27.12 骨*6 100 mg長骨 0.24 27.11 骨-7 100 mg長骨 2.22 27.17 骨-CA 50 mg鎖骨 7.95 ±1.2 27.012 齒 10 mg 450 ± 50 26.95 萃取空白組 0 26.80 無制組(NTC) NAb NAb a骨樣本的年齡不詳。齒樣本爲1歲。 b不適用 用於核酸最佳萃取和產量之測試骨樣本的量的變化是由 50 mg至200 mg,並且無論何時需要,收集之裂解溶液 上清液的體積在分離DNA之韵使用PrepFiler™裂解緩衝 液而被調整至200 μι 。當骨粉末的量由25 mg增加至50 mg的粉末時,DNA的總產量幾乎為兩倍(表格2)。進一 步增加骨粉末的量增加了 DNA產量,但DNA產量增加的量 和骨粉末的量不成正比例。此評估以三次重複進行。在 培養200 mg骨粉之後,所回收的裂解溶液上清液體積為 130 μί(相較於來自50 mg骨粉的回收200 μι)。因此, 處理多於200 mg的骨粉並沒有明顯增加DNA產量。 099131421 表單編號A0101 第24頁/共54頁 1003014903-0 201213805 表格2 : 骨-CA (mg) 總產量 (ng) 每克骨 之產量 IPCCt 數値 25 4.8 ±1 0.2 27.05 50 9.3 ±3 0.18 26.94 100 12.0 ± 3 0.12 27.03 200 21.6 ±6 0.11 26.89 萃取空白組 0 NA NA 無模雛制組(NTC) NA NA 26.85 於1至1 8小時的不同時間區間調查來自骨樣本核酸的萃取 程度。將50 mg之骨以一式三份萃取。DNA產量總結於 表格3。當以裂解溶液對骨樣本萃取的時間從1小時增加 至2小時,DNA產量增加了 1.54倍。然而,進一步增加培 養時間至18小時大體上沒有增加DNA產量。然而,長達18 小時的培養時間對萃取沒有不良影響。 表格3 : 裂解時間 (小時) 總產量 (ng) IPCCt 數値 1 5.2 ± 1 27.132 2 8.0 ± 1 27.047 4 8.5 ± 1.5 26,952 8 8.8 ±1.5 26.913 18 11.4+1 26.923 無麵控制組 NA 26.815 按照製造者之計畫書,針對STR分析而使用AmpFlstr® 099131421 表單編號 A0101 第 25 頁/共 54 頁 1003014903-0 201213805Bieberet ai,, "Isolation of DNA from Forensic Evidence,"Current Protocols in H uman G ene t- ICS, Supplement 26 (2000) ; Forensic DNA Pro filing Protocols, Metiiucls in Molecular Biology, vo1. 9 8, PJ Lincoln and J. Thomson, eds., Humana Press (1998) ° Applicants have found that when using PrepFiler's plan for adhesive materials containing solid nucleic acids and solid biological samples, use the text 099131421 Form No. A0101 No. 20 Page / Total 54 pages 1003014903-0 201213805 A lysing reagent solution with one or more detergents, chelating agents, reducing agents, salts and enzymes, nucleic acids can be more easily isolated and purified. The lysis solution improves the yield and efficiency of nucleic acids (e.g., genomic DNA) from adhesive materials, solid biological samples. The detergent can be polar or non-polar. Some examples of suitable cleansers include, but are not limited to, N-lauric myosinic acid (NLS), lauric acid sarcosine (also known as sar-cosyl), a derivative derived from sarcosine. Ionic surfactant; hexadecyltr i methyl ammonium bromide or cetyltrimethylammonium bromide (CTAB); deoxycholic acid; sodium citrate; sodium deoxycholate; twelfth base / 3-D- Maltose; thiol-N-methyl branamide; sodium lauryl sulfate; polyethylene glycol p-(l,1,3,3-tetramethylbutyl)-phenyl ether (generally called For Triton® X-100); and combinations thereof. In some embodiments, the cleaning agent comprises NLS in the range of 0.5 to 3% w/v. Some examples of suitable chelating agents include, but are not limited to, ethylene glycol diamine (EDTA), ethylene glycol bis(2-aminoethyl)-hydrazine, hydrazine, hydrazine, hydrazine in the range of about 250 to 750 mM. '-Tetraacetic acid (EGTA) with citric acid. Some examples of suitable reducing agents include, but are not limited to, tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE), and dithiothreitol (DTT) in the range of about 10 to 100 mM. (Freshly prepared before use). Some examples of suitable enzymes include, but are not limited to, caspase, chymotrypsin, pepsin, proteinase K, coagulase, staphylococcus in the final concentration range of 0.5 to 10 mg/ml in the lysis solution. V8 protease, pronase, papain, Bacillus sp. E1A protease, and trypsin. In some embodiments, the lysis solution is combined with a chelating agent at a pH of about 7.5 to 8.5, followed by a detergent and a salt, followed by a reducing agent solution and an enzyme. 099131421 Form No. A0101 No. 21 Page / Total 54 pages 1003014903-0 201213805 Preparation. In some embodiments, the chelating agent is prepared in a solution with a cleaning agent, with or without a salt, the reducing agent is freshly prepared, and the enzyme is in a 'liquid. Salts are in solution or present in detergent solutions. The Lok solution can then be combined to form a lysis solution prior to use. Alternatively, in some embodiments of the present teachings, the lysis solution can be prepared and then dried. λ; Donggan's lysis reagent can be dissolved before use. The method of such bundle drying is conventional and is known in the art as a result of the freshly prepared cleavage solution known to those skilled in the art. The result is that the component is not degraded or oxime, for example, a cause may exist in long-term storage or exposure. Total yield under light and thus reduced acid extraction and nucleic acid. In some embodiments, the adhesive material or solid biological material is cultured for about two hours from about to the next to release the cells from the adhesive material. The solid biological matrix is 56 〇c which is a commonly used temperature. In some embodiments, the natural or synthetic material is from about 4 G mo. (: culture for 40 knives to 1 hour. This extraction can be assisted by shaking. In some embodiments, the lysis solution further comprises a compound that protects the released nucleic acid and maintains their compatibility in downstream assays, for example, by way of example For the PCR test and in the specific DNA genotyping system, for example, the str test. After culturing the adhesive material or the solid biological sample, the sample can be centrifuged to granulate residual solid tissue or adhesive material. The resulting supernatant product comprises a nucleic acid. This supernatant is suitable for use in nucleic acid isolation and purification (using methods known to those skilled in the art or commercial core 1 as a separation product, such as pr epF i 1 er TM kit). This kit can be used to remove cell debris, residual contaminants and/or pCR inhibition 099131421 Form No. A0101 Page 22 / Total 54 Page 1003014903-0 201213805 In this tutorial In some embodiments, the nucleic acid molecule can then be separated from the solid matrix 'including but not limited to: bone; cartilage; kinetic band•' tendon; and teeth. In some embodiments, the biological sample is calcified, dried, dried, or otherwise in a natural or preserved state. In some embodiments, the 'solid biological sample is dispersed, comminuted, ground, or otherwise ground. Fine particles (eg powder). The yield of a nucleic acid (eg DN a ) varies depending on the age of the solid material, the amount of starting material and the q degradation or storage of the sample. The production of nucleic acids (eg DNA) from bone and tooth samples Summarized in Table 1 MA MA yield range from 100 mg long bone samples is from (L25 to 2.15 ng 'which is typical for such sample types because each bone sample is unique in the inclusion and state of the biological sample The values for the internal PCR control group (IPC) were determined by the Quantifiler® Human DNA Quantitative Kit (Applied Biosystems) compared to the value of the no template control group (NTC, Table 1). There was no significant increase in the bone sample q tested. If the DNA extract contains a PCR inhibitor, typically a sample is expected to be compared to the IPC of the NTC (the value is shifted above (Applied Biosystems, Quantif) Iler® Human DNA Quantitation Kit and Quantifiler® Y Male Human DNA Quantitative Kit. User Manual. PN 4344790 Rev. B, (2003)). Therefore, PCR inhibitors present in bone and tooth samples during DNA extraction It has been efficiently removed (using a lysis reagent solution followed by separation and purification with the PrepFilerTM kit reagent) 099131421 Form No. A0101 Page 23 of 54 1003014903-0 201213805 Table 1: Human DNA production from bone and teeth Sample a describes total yield (ng) IPCCT number tibia-1 100 mg long bone 1.9 27.05 bone-2 100 mg long bone 0.66 27.12 bone-3 100 mg long bone 1.19 26.96 bone-4 100 mg long bone 1.6 27.19 bone-5 100 mg long bone 0.8 27.12 bone*6 100 mg long bone 0.24 27.11 bone-7 100 mg long bone 2.22 27.17 bone-CA 50 mg clavicle 7.95 ±1.2 27.012 tooth 10 mg 450 ± 50 26.95 extraction blank group 0 26.80 no group ( NTC) The age of the NAb NAb a bone sample is unknown. The tooth sample is 1 year old. b Not applicable for the optimal extraction and yield of nucleic acids. The amount of bone sample varies from 50 mg to 200 mg, and whenever necessary, the volume of the supernatant of the lysing solution collected is separated in the DNA using PrupFilerTM. The buffer was adjusted to 200 μm. When the amount of bone powder was increased from 25 mg to 50 mg of powder, the total yield of DNA was almost double (Table 2). Further increase in the amount of bone powder increases DNA yield, but the amount of DNA production increase is not proportional to the amount of bone powder. This evaluation was repeated in triplicate. After culturing 200 mg of bone meal, the recovered lysis solution supernatant volume was 130 μί (compared to 200 μm from 50 mg bone powder). Therefore, treatment of more than 200 mg of bone meal did not significantly increase DNA production. 099131421 Form No. A0101 Page 24 of 54 1003014903-0 201213805 Table 2: Bone-CA (mg) Total Yield (ng) IPCCt per gram of bone 値25 4.8 ±1 0.2 27.05 50 9.3 ±3 0.18 26.94 100 12.0 ± 3 0.12 27.03 200 21.6 ±6 0.11 26.89 Extraction blank group 0 NA NA Moldless chick group (NTC) NA NA 26.85 The degree of extraction from the bone sample nucleic acid was investigated at different time intervals from 1 to 18 hours. 50 mg of bone was extracted in triplicate. DNA yields are summarized in Table 3. When the extraction time of the bone sample with the lysis solution was increased from 1 hour to 2 hours, the DNA yield was increased by 1.54 times. However, further increases in culture time to 18 hours did not substantially increase DNA production. However, up to 18 hours of incubation time has no adverse effects on the extraction. Table 3: Lysis time (hours) Total yield (ng) IPCCt number 値1 5.2 ± 1 27.132 2 8.0 ± 1 27.047 4 8.5 ± 1.5 26,952 8 8.8 ±1.5 26.913 18 11.4+1 26.923 Faceless control group NA 26.815 by manufacturer Project book, using AmpFlstr® 099131421 for STR analysis Form No. A0101 Page 25 of 54 1003014903-0 201213805

Identifiler®與MiniFiler™套組(Applied Bi〇Sys — terns)進行七個長骨樣本的DNA萃取(骨1至骨7)。結 果總結於表格4。此I d e n t i f i 1 e r套組擴增全部的1 6個 STR位點’以及MiniFiler套組擴增9個STR位點。在每 個測試樣本中,針對每一套組將最終的位點和全部可擴 增的位點比較。骨-4樣本提供完整的STR輪廓(使用兩套 組)。骨-6當使用Identifi ler套組擴增時沒有提供結 果,但使用MiniFiler™套組提供了僅4個位點的擴增。 所有其他的骨樣本以M i n i F i 1 er™套組測試可提供完整的 STR輪廓,且以Identifiler®套組測試提供了部分的 STR輪廓。此MiniFiler™套组係設計為從降解的DNA樣 本中獲得輪廓(J.J. Mulero,et al.,J.Identifiler® and MiniFilerTM kits (Applied Bi〇Sys — terns) were used for DNA extraction of seven long bone samples (bone 1 to bone 7). The results are summarized in Table 4. This I d e n t i f i 1 e r kit amplifies all 16 STR loci' and the MiniFiler kit amplifies 9 STR loci. In each test sample, the final locus is compared to the total expandable locus for each set of groups. The Bone-4 sample provides a complete STR profile (using two sets). Bone-6 did not provide results when amplified using the Identifiler kit, but the MiniFilerTM kit provided amplification of only 4 sites. All other bone samples were tested in a M i n i F i 1 erTM kit to provide a complete STR profile and a partial STR profile was provided with the Identifiler® kit test. This MiniFilerTM kit is designed to obtain contours from degraded DNA samples (J.J. Mulero, et al., J.

Forensic Sci. (2008) 53:838-852)。此結果指出 骨樣本為老化的且以不同程度降解。 表格4 : 樣本3 Iden邯ler®套組 MiniFiler™ 套組 骨-1 9/16 9/9 骨-2 9/16 9/9 骨-3 10/16 9/9 骨-4 16/16 9/9 眚-5 9/16 9/9 骨-6 0/16 4/9 骨-7 15/16 9/9 a骨樣本的年齢不詳° 099131421 表單煸號A0101 第26頁/共54頁 1003014903-0 201213805 在-些具體實施例中’本教示包括使用範圍在僅有微量 生物材料可能存在料候的多個樣本。樣本量可以範圍 是每-管中由5。至20〇岐之範圍的飼化組織或固體生物 性樣本,然、後結合上清液且在分離和純化前經由標準方 法濃縮。 〇 在本教示中之-些具體實_中,接著核酸分子可由黏 著性材料分離’其包括但不限於:σ香糖、雪祐屁股、 菸蒂、黏著薄膜、黏著標籤、貼紙、皮膚貼附物、伴封 封口、郵票與經由膠帶剝離之乾燥的血液、乾燥的唾液 ,包括但不限於灰塵、土壌、汙垢綱紋的環境採樣以 及膠帶。在-些具體實施射,皮膚—物包括但不限 於:EEG或EKG電子電極;可轉移的屬騰;皮膚渗透之化 學物質貼片以及傷口照護敷料。在—些具體實施例中, 膠帶包括但不限於:膠帶;運動膠帶;法醫膠帶;等等Forensic Sci. (2008) 53:838-852). This result indicates that the bone sample is aged and degraded to varying degrees. Table 4: Sample 3 Iden邯ler® Set MiniFilerTM Set Bone-1 9/16 9/9 Bone-2 9/16 9/9 Bone-3 10/16 9/9 Bone-4 16/16 9/ 9 眚-5 9/16 9/9 Bone-6 0/16 4/9 Bone-7 15/16 9/9 The age of the bone sample is unknown. 099131421 Form nickname A0101 Page 26 of 54 1003014903-0 201213805 In the specific embodiments, the present teachings include the use of multiple samples ranging from the presence of trace amounts of biological material. The sample size can range from 5 in each tube. Feeding tissue or solid biological samples up to 20 ,, then combined with the supernatant and concentrated by standard methods prior to isolation and purification. In the present teachings, the nucleic acid molecules may be separated by an adhesive material, including but not limited to: sigma, snow, buttocks, cigarette butts, adhesive films, adhesive labels, stickers, skin patches. , with seals, stamps and dried blood stripped by tape, dry saliva, including but not limited to dust, earthworms, environmental sampling of dirt and tape. In some specific implementations, skin-like materials include, but are not limited to, EEG or EKG electronic electrodes; transferable genus; skin-permeable chemical patches and wound care dressings. In some embodiments, the tape includes, but is not limited to: tape; sports tape; forensic tape;

099131421 。在-些具體實施例中,貼紙包括但不限於信封、再黏 紙'郵票等等。 使用所揭露之裂解峨溶液、PrepFileH緩衝液與 EZ1 DNA Investigator套組(Qia · scn, Valencia, CA)之來自包含黏著劑(例如终蒂、 ^ 口香糖、膠帶剝離、 信封和郵票)的樣本之DNA產量的比較顧_ 早乂.居不於表格5。一般 來說,針對勝帶剝離和於蒂樣本’使用所揭露的裂解試 劑之遍產量相較於使用PrepFiler^解緩衝液所獲得 的產量為高。相似地,使騎揭露的裂解_溶液之三 個測試口香糖樣本中的兩個的DNA產蕃私 置較高。樣本通常為 類似量的生物材料(見範例I和Iv) ’ 因為此評估涉及使 用法醫實驗室中可能遭遇的真實世界樣本種類,樣本種 表單編號 A0101 第27頁/共54頁 1003014903-0 201213805 類並沒有完全統一。因此,此DNA生成產量有用於測量裂 解試劑溶液的整體表現。已觀察到當使用PrepFiler裂 解緩衝液時,每個膠帶剝離和口香糖的樣本釋出大量的 黏著劑。對於膠帶剝離樣本而言,一些黏著劑的團塊可 在進一步PrepFiler計畫書處理前被移除,然而,在許 多此類樣本中,磁性顆粒無法形成丸狀物,以及一些此 類樣本必須在PrepF i 1 er計畫書中的清洗步驟期間離心 。裂解試劑溶液在萃取過程期間具有更加少量的黏著劑 釋出。因此,磁性顆粒在隨後的PrepFiler清洗步驟期 間形成較強的丸狀物,這導致核酸回收包括(DNA產量)的 改善。經由離心將小張紙片自於蒂樣本移除。Sherman品 牌的捲终紙是紫色的,並且在PrepFiler™裂解條件下觀 察到紫色染劑釋出。此外,對於所有研究個案類型樣本 之IPC CT數值與針對NTC所得數值相似,這說明將PCR抑 制劑從生物性樣本和受質中有效移除(表格5)。 099131421 表單編號A0101 第28頁/共54頁 1003014903-0 201213805 Ο099131421. In some embodiments, the sticker includes, but is not limited to, an envelope, a re-adhesive stamp, and the like. DNA from samples containing adhesives (eg, terminal syrup, chewing gum, tape stripping, envelopes, and stamps) using the disclosed lysing solution, PrepFile H buffer, and EZ1 DNA Investigator kit (Qia scn, Valencia, CA) Comparison of production _ 早乂. Not in Table 5. In general, the throughput of the disclosed lysis reagents for the ribbon stripping and the pedicle sample was higher than that obtained with the PrepFiler buffer. Similarly, the DNA production of two of the three test chewing gum samples of the disclosed lysing solution was higher. The sample is usually a similar amount of biomaterial (see Examples I and Iv) 'Because this assessment involves the use of real-world sample types that may be encountered in forensic laboratories, sample species form number A0101 Page 27 of 54 pages 1003014903-0 201213805 Not completely unified. Therefore, this DNA production yield is used to measure the overall performance of the lysis reagent solution. It has been observed that when using PrepFiler lysis buffer, each tape stripping and chewing gum sample releases a large amount of adhesive. For tape stripping samples, some of the adhesive agglomerates can be removed prior to further PrepFiler program processing, however, in many of these samples, magnetic particles cannot form pellets, and some such samples must be Centrifuge during the washing step in the PrepF i er program. The lysis reagent solution has a smaller amount of adhesive released during the extraction process. Therefore, the magnetic particles form stronger pellets during the subsequent PrepFiler washing step, which results in an improvement in nucleic acid recovery including (DNA yield). Small sheets of paper were removed from the pedicle sample by centrifugation. The Sherman brand's final roll paper was purple and the purple dye release was observed under PrepFilerTM lysis conditions. In addition, the IPC CT values for all study case type samples were similar to those for NTC, indicating effective removal of PCR inhibitors from biological samples and substrates (Table 5). 099131421 Form No. A0101 Page 28 of 54 1003014903-0 201213805 Ο

表格5 :由長骨樣本81之STR輪廊 樣本 麵試劑溶液 PrepFiler™ mmm DNA總產量 (ng)a IPCOr DNA總產® (ng) IPCCt 膠帶剝離 ,帶+2pL血液0 40 26.6 14 27.4 膠带剝離之2 μι·血液 20 27.3 17 27 膠帶+ 5 (JL唾液b 143 27.1 64 26.8 膠帮剝離之5 uUl液 7 26.9 3 27.4 膠帶剝離,襯衫袖口 0.6 26,6 NDC ND 膠帶刹離,襯挪口 4 26,7 ND ND 膠帶剝離,襯衫領子 2.5 26.8 ND ND 膠带剝離 > 襯衫領子 0.6 26.9 ND ND 受質空白組 0 26.8 0 26.8 萃取空白組 0 27.0 0 27.0 Winterfresh 7 27.0 15 26.4 Doublemint 6 27.1 3 27.3 Orbit 20 27.1 19 26.6 Extra White 27 28.1 ND ND Airwave (嚼2分鐘) 7 27.8 ND ND Airwave (嚼40分鐘) 30 27.7 ND ND Blast Mentos Berry-Lime 30 27.7 ND ND 萃®^白組 0 27.1 0 27.1 薛蒂 Marlboro 174 26.7 25 27.6 Marlboro Menthol Light 75 26.7 39 27.1 Sherman 424 26.6 111 29,0 Gauloises Menthol 76 26.7 22 28.0 Marlboro Menthol Light® 35 26.7 3 26.8 Holiday Gold 12 26‘9 ND ND Holiday Menthol 37 26.5 ND ND 受質空白組 0 26.7 0 26J 萃取空白組 0 26.7 0 26.7 體檀爲b〇uL。所呈現的量爲平均値。 .. <=血液或5队唾液直接加至1.5咖x 2.5 cm的膠帶片段。 禾確定 片段的口香糖’除了 Blast Mentos Berry_Lime ’ 皆爲 Wrig|ey*s 品牌· 於分析前’將樣外_ 72 4姆。此72 /j姆之觀麵豳爲4·15X。 在本教示中之一些具體實施例中,可使用Tris_cl裂解溶 液以從粗斜紋布材料中分離核酸分子,該粗斜紋布材料 係包含於表面或内嵌在生物流想樣本,其包括但不限於 099131421 表單編號A0101 第29頁/共54頁 1003014903-0 201213805 血液、組織、尿液、唾液 ,舉例來說,毛髮糞 ° . 古膚(例如包含於指紋t的皮膚細 臉頰細胞、陰道細胞、皮 、 ^ >於盤細胞的羊水與包含胎兒細胞的 胞、口腔樣本、包. a·物味體矸為潮濕的、濕的、乾燥的或 羊水)以及精液°生" .,.. 。在〆些具體實施例中’生物流 附著於粗斜紋布讨料 f g 體樣本可以是發現於環境的樣本(例如4壤h在其他具 體實施例中,㈣露的為同時裂解生物流體材料中的細 H装取生物流體材料以及從基質中沖 胞而從粗斜紋♦材料年 提出核酸的方法。在-些具财關巾’此方法亦可包 括加熱或培養伴隨包含生物流禮材料的粗斜紋布受質之Table 5: STR porch sample surface reagent solution from long bone sample 81 PrepFilerTM mmm Total DNA production (ng) a IPCOr DNA total production® (ng) IPCCt tape stripping with +2pL blood 0 40 26.6 14 27.4 Tape stripping 2 μι·血20 27.3 17 27 Tape + 5 (JL saliva b 143 27.1 64 26.8 5 5 UUl solution 7 26.9 3 27.4 Tape peeling, shirt cuffs 0.6 26,6 NDC ND Tape brake, lining 4 26 , 7 ND ND tape stripping, shirt collar 2.5 26.8 ND ND tape stripping > Shirt collar 0.6 26.9 ND ND Acceptance blank group 0 26.8 0 26.8 Extraction blank group 0 27.0 0 27.0 Winterfresh 7 27.0 15 26.4 Doublemint 6 27.1 3 27.3 Orbit 20 27.1 19 26.6 Extra White 27 28.1 ND ND Airwave (chewing 2 minutes) 7 27.8 ND ND Airwave (chewing 40 minutes) 30 27.7 ND ND Blast Mentos Berry-Lime 30 27.7 ND ND Extract®^White Group 0 27.1 0 27.1 Chedi Marlboro 174 26.7 25 27.6 Marlboro Menthol Light 75 26.7 39 27.1 Sherman 424 26.6 111 29,0 Gauloises Menthol 76 26.7 22 28.0 Marlboro Menthol Light® 35 26.7 3 26.8 Holiday Gold 12 26'9 ND ND Holiday Menthol 37 26.5 ND ND Acceptance blank group 0 26.7 0 26J Extraction blank group 0 26.7 0 26.7 Body sandalwood is b〇uL. The amount presented is the average 値.. <= blood or 5 The team's saliva is directly added to the 1.5 coffee x 2.5 cm tape segment. Wo determines the fragment of the chewing gum 'except Blast Mentos Berry_Lime' are Wrig|ey*s brand · before the analysis 'will be outside the sample _ 72 4 m. This 72 / j view of the face is 4.15X. In some embodiments of the present teachings, a Tris_cl lysis solution can be used to separate a nucleic acid molecule from a denim material that is included on a surface or embedded in a biological flow sample, including but not limited to the 099131421 form. No. A0101 Page 29 of 54 1003014903-0 201213805 Blood, tissue, urine, saliva, for example, hair manure °. Essence (for example, skin cheek cells, vaginal cells, skin, included in fingerprint t) > Amniotic fluid in the cells of the disk and the cells containing the fetal cells, oral samples, packets. A. The odor of the body is moist, wet, dry or amniotic fluid) and semen ° " .. In these specific embodiments, the biological flow attached to the denim material fg body sample may be a sample found in the environment (eg, 4 soil h in other embodiments, (4) exposed to simultaneously lyse the fine material in the biological fluid material H. The method of extracting biological fluid material and extracting nucleic acid from the matrix to extract nucleic acid from the rough twill material. In some cases, the method may also include heating or cultivating the denim with the biological flow material. Quality

Tris-Cl裂解溶液。在一些具體實施例t,將Tris-Cl裂 解溶液離心’ β從受質分離包含核酸的裂解物。 在本教示中的一些具體實施例中提供了組合物,其中樣 本可以用包含Tris-氯(Tris-Cl )、至少一個清潔劑、 螫合劑、還原劑以及酵素每一者以及其結合物之Tris_cl 裂解溶液處理,以從粗斜紋布受質樣本中萃取出核酸。 清潔劑可以為—或更多的N-月桂傭^胺酸、去氧膽酸鈉、 CTAB、十二基石—d—麥芽糖甘、壬驗基_N_甲基麩醯胺、 d,3-四甲基丁基笨基醚Tris-Cl lysis solution. In some embodiments t, the Tris-Cl lysate solution is centrifuged '[beta] to separate the lysate comprising the nucleic acid from the substrate. In some embodiments of the present teachings, compositions are provided wherein the sample may be Tris_cl comprising Tris-Cl, at least one detergent, a chelating agent, a reducing agent, and each of the enzymes and combinations thereof. The lysis solution is treated to extract nucleic acids from the denim substrate. The cleaning agent may be - or more N-lauric sulphate, sodium deoxycholate, CTAB, dodecyl-d maltose, sputum _N_methyl glutamine, d, 3- Tetramethylbutyl stupyl ether

聚乙二醉P_U 硫酸納(SDS)、以及其結合物。螫合劑可以為一或更多 的四醋酸乙二醇(EGTA)與四醋酸乙二胺(EDTA)、棒 檬酸以及其結合物。還原劑可以為: 基)膦(TCEP)二硫 的一^竣乙 、鮮醇DTE)以及二硫蘇糖薛广 DTT)。酵素可以為 “辣糖知( 酶、胃蛋白酶、蛋㈣κ Γ 冬酶、騰凝乳蛋白 、鏈黴蛋白酶、木瓜崎…凝血酶、葡萄球菌屬V8蛋白酶 099131421 表單編號腿。1 $ 30 Κ/共牙二桿菌SP. EU蛋白酶與胰蛋 1〇〇3〇149〇3~| 201213805 白酶。鹽類可以為一或更多的氯化鈉、氯化鉀、氯化鎂 、氣化錳以及其氟化和碘化的形式。此裂解溶液可具有 範圍自 5.0 - 12.0,或 5.1、6.0、7.0、8.0、9.0、 10. 0與11. 0以及在每一整數的區間之pH。 在一些具體實施例中,樣本可包含從粗斜紋布材料中萃 取的核酸,粗斜紋布材料係包括但不限於,包括藍色、 暗藍色、黑色、石洗、酸洗以及諸如此類的粗斜紋布料 。在本教示額外的具體實施例中,方法被描述了其中核 酸可從樣本中萃取的方法,包含以下步驟:將樣本以包 含T r i s - C1、一或更多清潔劑、整'合劑、還原劑、鹽類和 酵素的溶液培養;以及萃取上清液。培養可以是在室溫 35°C、40°C、41°C、42°C、43°C、44°C、45°C、50° C、51°C'52°C、53°C、54°C、55eC、56°C、57°C、 58°C、59 °C、60°C、65°C與 70°C,以及其區間内。 此方法可進一步包含以下步驟:將培養的溶液離心以從 上清液移除固體物,以及處理上清液以分離核酸。 在一些具體實施例中,PCR抑制劑可在核酸萃取步驟的期 間被萃取或釋放至裂解物或沖提物中,這導致粗劣品質 的DNA。由生物流體樣本所萃取或回收的核酸品質可能對 於例如,舉例來說,定量、偵測與特定核酸或物種的基 因分型之核酸分析步驟具不利的影響。 在一些具體實施例中,Tris-C1可為從10 mM至600 mM 的濃度,以及5至12之pH值。在一些具體實施例中,清潔 劑的存在可以是從0. U至5. 0%,以及螫合劑的存在可以 是7.0至8. 5之pH值下從約1.0 mM至600 mM (以0.5 -1M NaOH調整pH)。合適鹽類的一些例子包括但不限於 099131421 表單編號A0101 第31頁/共54頁 1003014903-0 201213805 ’於約1 mM至1 Μ之範圍的氯化鈉、氯化鉀、氣化鎂、氯 化猛以及其氟化物和峨化物形式。在一些具體實施例中 ’酵素濃度是在1 mg/uL至50 mg/mL之範圍以及還原 劑濃度是在10 mM至1 Μ之範圍。 使用不同種類、重量和顏色的粗斜紋布料(自j〇_Ann’ sPolyethylene II is intoxicated with P_U sodium sulphate (SDS), and combinations thereof. The chelating agent may be one or more of ethylene glycol tetraacetate (EGTA) and ethylene tetraacetate (EDTA), citrate, and combinations thereof. The reducing agent may be: phosphine (TCEP) disulfide, glycerol (DTE), and dithiothreitol Xueguang DTT). The enzyme can be called "Spicy Sugar (Enzyme, Pepsin, Egg (4) κ Γ 酶, Enzymatic Milk Protein, Pronase, Papaya... Thrombin, Staphylococcus V8 Protease 099131421 Form Number Leg. 1 $ 30 Κ / Total Bacillus licheniformis SP. EU protease and pancreatic egg 1〇〇3〇149〇3~| 201213805 White enzyme. Salts can be one or more of sodium chloride, potassium chloride, magnesium chloride, manganeseated manganese and its fluorinated And iodinated forms. The cleavage solution can have a pH ranging from 5.0 - 12.0, or 5.1, 6.0, 7.0, 8.0, 9.0, 10. 0 and 11.0, and in the interval of each integer. In some embodiments The sample may comprise nucleic acids extracted from denim material, including but not limited to, denim fabrics including blue, dark blue, black, stone wash, pickling, and the like. Additional teachings in the present teachings. In a specific embodiment, the method is described in a method in which a nucleic acid can be extracted from a sample, comprising the steps of: including a Tris-C1, one or more detergents, a mixture of agents, a reducing agent, a salt, and an enzyme. Solution culture; Take the supernatant. The culture can be at room temperature 35 ° C, 40 ° C, 41 ° C, 42 ° C, 43 ° C, 44 ° C, 45 ° C, 50 ° C, 51 ° C '52 ° C , 53 ° C, 54 ° C, 55 eC, 56 ° C, 57 ° C, 58 ° C, 59 ° C, 60 ° C, 65 ° C and 70 ° C, and within the interval. This method may further include the following Step: Centrifuging the culture solution to remove solids from the supernatant, and treating the supernatant to separate nucleic acids. In some embodiments, the PCR inhibitor can be extracted or released to the lysate during the nucleic acid extraction step Or in the extract, this results in poor quality DNA. The quality of the nucleic acid extracted or recovered from the biological fluid sample may be, for example, a nucleic acid analysis step for quantifying, detecting, and genotyping a particular nucleic acid or species.至 U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U U Up to 5.0%, and the presence of a chelating agent may be from about 1.0 mM to 600 mM at a pH of 7.0 to 8.5 (pH adjusted with 0.5 -1 M NaOH). Some examples include, but are not limited to, 099131421 Form No. A0101 Page 31 / Total 54 Page 1003014903-0 201213805 'Sodium chloride, potassium chloride, magnesium sulphate, chlorinated and its fluorine in the range of about 1 mM to 1 Μ And chelated forms. In some embodiments, the enzyme concentration is in the range of 1 mg/uL to 50 mg/mL and the reducing agent concentration is in the range of 10 mM to 1 Torr. Use thick twill fabrics of different kinds, weights and colors (from j〇_Ann’ s

Fabrics,San Mateo,CA獲得)分析Tris-Cl 裂解試 劑溶液。基本上,將血液應用於每一粗斜紋布種類以及 將5 mm之粗斜紋布打孔由血點的中央移除(約有1 ^乾 燥的 jk液)。使用 Identifi ler®套組(Appl i ed Biosystems)在列舉於表格β的粗斜紋布樣本回收之⑽a 而比較Intercolor Balance (ICB),其中一些包含揭 露於第1圖之款藍染料、酸洗處理、石洗處理、冰洗處理 、黑色染料、紋理、印花以及不同重量與表面處理,接 著使用伴隨所揭露之Tris-C卜緩衝裂解試劑溶液、 PrepFi ler™裂解緩衝液和 identifi ler®套組(Ap_ plied Biosystems)的核親窣取。一般而言,使用所 揭露之Tris-C卜緩衝裂解試劑寧液之])NA品質足以獲得 每一個測試樣本完整的STR輪廓。這些結果顯示即使在靛 藍、黑色染劑以及化學處理(已知的PCR抑制劑)存在下, 所揭露之T r i s - C卜緩衝裂解試劑溶液可提供高品質的核 酸0 099131421 表單編號A0101 第32頁/共54頁 1003014903-0 201213805 表格6 : 一粗斜紋布ID 描述 酿紋布旧 描述 10OZ 仿舊 STR 18 70Z藍色STR煙管補 —-2_ 10.5OZDK 藍色 stove 19 loozsw水洗粗斜tote — 5.80Z未漂白粗斜紋布 20 50Z藍細紋 斜紋布 4 90ZDK藍色煙管褲 21 90Z藍色紋理st ____5 8 0Z藍隹煙管褲D 22 90Zmed藍色str粗斜赫 6 ^ 40ZDK藍色粗斜紋布 24 6.50Z靛藍粗斜紋布 7 80Z0K藍色粗斜紋布 25 70Z It藍色竹節粗斜麻 - 8 管褲 27 sbl水洗(wsh)粗斜絞布 1002 —-1_ 9,9〇z m&fm st 28 28. _ 10 11OZ黑色STR粗斜紋布 29 10OZ 仿舊 nost _ 11 5 0Z藍色斜紋(XhatGh)粗斜紋 布 30 12.50Z «* str _ 12 12, L BL冰洗 31 40ZII藍鎌斜紋~~ 13 β OZ綱斜紋(xhatch)粗斜紋 布 32 110Zlt藍色蚶酿_ —Jl_ 10OZ靛藍水洗粗斜紋布 34 4〇Zlt藍色粗斜紋布 — 15 1002LT 藍色 STRsto 36 70Z藍色粗斜紋布 16 10.5OZmed 藍色斜紋(xhatch) 37 90Z光館藍水洗 _ 17 9.750ZU 藍色 stove 38 70Z産色sfr煙管補Fabrics, San Mateo, CA)) Analysis of the Tris-Cl lysis reagent solution. Basically, blood is applied to each denim type and a 5 mm denim punch is removed from the center of the blood spot (about 1 ^ dry jk solution). Compare Intercolor Balance (ICB) with the Identifi ler® kit (Appl i ed Biosystems) in the denim sample sample listed in Table β, some of which contain the blue dye, pickling treatment, stone disclosed in Figure 1. Wash, ice wash, black dye, texture, print, and different weights and finishes, followed by the accompanying Tris-C Bu Buffer Lysis Reagent Solution, PrepFi lerTM Lysis Buffer and identifi ler® Kit (Ap_ plied) Biosystems) nuclear relatives. In general, the NA quality of the disclosed Tris-C Buffer Cleavage Reagents is sufficient to obtain a complete STR profile for each test sample. These results show that even in the presence of indigo, black stains and chemical treatments (known PCR inhibitors), the disclosed T ris - C Bu buffer lysate solution provides high quality nucleic acids 0 099131421 Form No. A0101 Page 32 / Total 54 pages 1003014903-0 201213805 Form 6: A denim ID Description Old grain description 10OZ Distressed STR 18 70Z blue STR pipe filling -2_ 10.5OZDK Blue stovetop 19 loozsw washed thick oblique tote — 5.80Z not Bleached denim 20 50Z blue fine grain twill 4 90ZDK blue tobacco pipe pants 21 90Z blue texture st ____5 8 0Z blue 隹 pipe pants D 22 90Zmed blue str thick oblique hem 6 ^ 40ZDK blue denim 24 6.50Z 靛 blue denim 7 80Z0K blue denim 25 70Z It blue bamboo thick oblique hemp - 8 pants 27 sbl washed (wsh) thick oblique cloth 1002 —-1_ 9,9〇z m&fm st 28 28. _ 10 11OZ black STR Rough twill 29 10OZ distressed nost _ 11 5 0Z blue twill (XhatGh) denim 30 12.50Z «* str _ 12 12, L BL ice wash 31 40ZII blue twill ~~ 13 β OZ twill (xhatch) denim 32 110Zlt blue brewing _ —Jl_ 10 OZ 靛 blue washed denim 34 4 〇 Zlt blue denim - 15 1002LT blue STRsto 36 70Z blue denim 16 10.5OZmed blue twill (xhatch) 37 90Z light blue wash _ 17 9.750ZU blue stove 38 70Z Color sfr pipe

在本教示的一些具體實施例中,接著使用Tris-Cl-緩衝 裂解試劑溶液,核酸分子可從粗斜紋布中分離。In some embodiments of the present teachings, the nucleic acid molecules can then be separated from the denim using a Tris-Cl-buffered lysis reagent solution.

從骨、裔和一些含有黏著劍的材料獲得的STR輪廓之毛細 管電泳電子顯微照相為典型此類樣本的種類。此外,STR 輪廓證實所獲得的DNA不具任何PCR抑制劑(資料未顯示 ’Stray et al., Forensic Science International: Genetics Supplement Series 2 (2009) - 160 ’併入本文以供參考)。顯示此裂解試劑溶液 破壞鈣化組織基質,達成從粉碎的骨和齒樣本以及從黏 著性材料(例如膝帶、口香糖、信封、郵票和終蒂)中有 效率的DNA萃取。如同第1圖至第4圖所顯示,粗斜紋布材 料的STR輪廓之結果證實所獲得的DNA不具任何PCR抑制 劑。顯示Tris-C卜緩衝裂解試劑溶液達成從粗斜紋布樣 099131421 本中有效DNA萃取。 表單編號A0101 裂解試劑溶液及Tris-Cl-緩衝裂解 第33頁/共54頁 1003014903-0 201213805 試劑溶液都導致核酸回復的改善、改善DNA分離、純化並 且DNA不具有危及或阻礙進一步分析(例如PCR、即時聚合 酶鏈鎖反應以及STR輪廓)的干擾材料與雜質。 在本教示的其他具體實施例中,使用本文所描述的方法 如同上文所討論而獲得之從指紋回收的核酸可被用於鑑 定有機體(包含核酸的生物材料或生物樣本從該有機體而 被得到)。指紋圖像可結合或分離於核酸鑑定試驗而用於 和法醫資料庫比較,其包括但不限於指紋收集及/或指紋 資料庫。指紋是已知的法醫鑑定工具,並且全世界存在 數種指紋資料庫和收集,以用於鑑定和碟認/驗證身份之 目的。利用從指紋獲得核酸的優點提供了進一步的確認 與確切的鑑定證據,|且進一步將所鑑定之個體與外表 以及地點或者獲得指紋核酸之物體連結。 在本教示的其他具體實施例中,使用本文所描述的方法 而獲得之從粗斜紋布回收的核酸可用於鑑定有機體(如同 上文所討論’包含核酸的生物材料或生物樣本從該有機 體而被獲得)。 本教示亦針對用於從基質萃取核酸之套組,基質包括但 不限於,鈣化或者硬化成固體狀態之生物材料、被認為 包含核酸之黏著或具黏性的材料以及被認為包含核酸的 粗斜紋布。此類套組可用於考古、刑事、法醫、人類鑑 099131421 疋以及利用上文描述之方法的研究。在一些具體實施例 中基本的套組可包含具有能夠使核酸從基質釋放的裂 解/奋液的4器、黏著及/或具黏性材料或粗斜紋布材料。 套組亦可隨選地包含使㈣指示。此套组亦可包含其他 隨選的套組成份,例如,舉例來說 表軍編號A0101 帛34頁/共54頁 包含聚合物和清潔 1003014903-0 201213805 劑的溶液、磁性吸力之顆粒、—或更多清洗溶液、核失 沖提溶液、核酸萃取控制組、磁性裝置以及教育4 z敲 與限制錯誤使用的計畫書與手冊。套組中各種二2用= 子與磁性裝置的數量亦可依照數個因素(例如最隹官 /或過程的靈敏度)而變化。在這些教示的範圍内提^及 於手動應狀制的測試套組或驗自_本製備、、用 應建立、偵測器或分析儀之使用的測試套組。 本領域的人員了解所採用_測技術—般為不受限㈣Capillary electrophoresis electron micrographs of STR profiles obtained from bones, descent, and some materials containing adhesive swords are typical of such samples. Furthermore, the STR profile confirmed that the DNA obtained did not have any PCR inhibitors (data not shown in 'Stray et al., Forensic Science International: Genetics Supplement Series 2 (2009) - 160' incorporated herein by reference). This lysis reagent solution is shown to disrupt the calcified tissue matrix for efficient DNA extraction from comminuted bone and tooth samples as well as from adhesive materials such as knee bands, chewing gum, envelopes, stamps and final pedicles. As shown in Figures 1 to 4, the results of the STR profile of the denim material confirmed that the obtained DNA did not have any PCR inhibitor. The Tris-C Bu buffered lysis reagent solution was shown to achieve efficient DNA extraction from denim-like 099131421. Form No. A0101 Lysis Reagent Solution and Tris-Cl-Buffer Cleavage Page 33 of 54 1003014903-0 201213805 Reagent solutions all lead to improved nucleic acid recovery, improved DNA isolation, purification and no DNA hazard or hinder further analysis (eg PCR) , Instant polymerase chain reaction and STR profile) interfere with materials and impurities. In other specific embodiments of the present teachings, nucleic acids recovered from fingerprints obtained using the methods described herein as discussed above can be used to identify organisms from which biological materials or biological samples comprising nucleic acids are obtained. ). Fingerprint images can be combined or isolated from nucleic acid identification assays for comparison with forensic databases, including but not limited to fingerprint collection and/or fingerprint databases. Fingerprints are known forensic identification tools, and there are several fingerprint databases and collections around the world for identification and identification/validation purposes. The use of advantages in obtaining nucleic acids from fingerprints provides further confirmation and definitive identification evidence, and further links the identified individuals to appearances and locations or objects that acquire fingerprint nucleic acids. In other specific embodiments of the present teachings, nucleic acids recovered from denim obtained using the methods described herein can be used to identify organisms (as discussed above, biomaterials or biological samples comprising nucleic acids are obtained from the organism) ). The teachings are also directed to kits for extracting nucleic acids from a matrix, including but not limited to, calcified or hardened biological materials, materials believed to contain adhesion or adhesion of nucleic acids, and denim considered to contain nucleic acids. . Such kits can be used for archaeological, criminal, forensic, human identification 099131421 疋 and research using the methods described above. In some embodiments, the basic kit can comprise a 4-, adhesive and/or viscous material or denim material having a cleavage/excitation capable of releasing nucleic acids from the matrix. The kit may also optionally include (4) instructions. This kit may also contain other optional kit components, such as, for example, Form No. A0101 帛 34 pages / Total 54 pages containing polymer and cleaning solutions for 1003014903-0 201213805, magnetic suction particles, or More cleaning solutions, nuclear loss extraction solutions, nucleic acid extraction control groups, magnetic devices, and educational programs and manuals that limit misuse. The number of sub-types and magnetic devices in the set can also vary depending on several factors (e.g., the sensitivity of the most official/process). Within the scope of these teachings, test kits for manual testing or test kits for use in the preparation, use, detector or analyzer are used. Those in the field understand that the technology used is generally not limited (4)

。反之,多種核酸萃取方法是在所揭露組合 的 ^ 万法和 套組的《之内(假設分_㈣錢贿或具有 材料之核酸)。 ;. Conversely, a variety of nucleic acid extraction methods are within the "methods and sets" of the disclosed combination (assuming a sub-(four) bribe or a nucleic acid with a material). ;

雖然本發明的原則已與特定的具體實痒例結合而描述, 應清楚了解作這些描述僅以範例的方式並且不意圖限制 本發明的範圍。已於本文揭露者已提供作為說明和描述 之目的。其非意圖為窮舉的或限制所揭露者為精確的描 述形式。許多修改和變化對本領域技術從事者將為明顯 的。選擇與描述揭露者係為了最:佳地解釋所描述領域揭 露之具體實施例的原則與實傺處用(,從而使其他本領域 之技術人員了解各種具體實施例以及考量各種適合特定 用途的修改。其意圖將所揭露的範圍經由下列申請專利 範圍及其同專物而定義。 本教示的方面可參照下列範例而進一步了解,其不應以 任何方式解釋為限制本教示之範圍。 範例 本領域具一般技藝之技術人員將了解許多修改、替代以 及同等物為可能的。所有此類修改、替代以及同等物皆 099131421 表單編號A0101 第35頁/共54頁 1003014903-0 201213805 思圖包含於本文。 酸之 下列步驟反廡了 n - <劑以及可被採用於從認為包含核 15生物基質與黏& t ϊ嫌丄 、者性受質中萃取核酸的步驟。 .樣本預處理 使用 溫和的清潔、 工s 谷液風乾隔夜,並使用連接到Dremel 、之打磨石移除休 潔骨與齒樣’、層(Dremel,Madison, WI )而清 清、° &大塊的骨頭被切成小塊。使用新鮮或 月潔過的研磨器(如 pr〇d a Cryo-mill, BioSpect ucts, Bart 1·, 磨姑认x esviUe,OK)研磨骨與齒塊。將研 、月或齒粉末儲存於 將插過的菸蒂儲^认〜、 濱( 子;室溫。將過濾材料移除並將接觸皮 V如手指声嘴p、 塊。 、 J的私紙底部第一個5 mm部分切成三 將。爵過的口香糖槐 中弄平 樣本儲存於室溫。將膠在乾淨的培養皿 儲疒、:3㈣厚)。為了硬化而關閉蓋子並且將培養| 八;0 C數個小時。將硬北的燦巍成8相同尺寸之部 使用勝的其中-部分作為觀的萃取。 備各種來源的剝離剝離樣本。從每-樣本中使用1.5Although the principles of the present invention have been described in connection with the specific embodiments of the present invention, it should be understood that the description is not intended to limit the scope of the invention. It has been disclosed herein for the purposes of illustration and description. It is not intended to be exhaustive or to limit the invention to the precise form. Many modifications and variations will be apparent to those skilled in the art. The selection and description of the present invention are intended to best explain the principles and practice of the specific embodiments disclosed herein. The scope of the present disclosure is to be understood as being limited by the following examples, which are not to be construed as limiting the scope of the present teachings. Those skilled in the art will recognize that many modifications, substitutions, and equivalents are possible. All such modifications, substitutions, and equivalents are 099131421 Form No. A0101 Page 35 of 54 1003014903-0 201213805 Thoughts are included herein. The following steps of the acid counteract the n- <agent and the steps that can be used to extract nucleic acids from the core substrate and the susceptor containing the nuclear 15 biomolecule. The sample pretreatment uses mild Clean, work s Valley liquid air-dried overnight, and use the connection to Dremel, the grinding stone to remove the bone and teeth ', layer (D Remel, Madison, WI) and clear, ° & large pieces of bone are cut into small pieces. Use fresh or moon-cleaned grinders (eg pr〇da Cryo-mill, BioSpect ucts, Bart 1·, 磨Recognize x esviUe, OK) Grind the bone and the tooth block. Store the grinding, month or tooth powder in the cigarette butt that will be inserted into the cigarette butt, and (the room temperature; remove the filter material and contact the skin V as a finger The first 5 mm part of the bottom of the private paper of J is cut into three. The sample of the scented gum is flattened and stored at room temperature. The glue is stored in a clean culture dish: 3 (four) thick In order to harden, the lid is closed and will be cultured | eight; 0 C for several hours. The hard-top candied into 8 parts of the same size is used as the observation of the extraction. Samples of peeling and peeling from various sources are prepared. Use 1.5 per sample

Cm Υ 〇 r 2.5 cm塊膠帶(包含生物性樣本)來進行。在經 帶剝離練移除之前將血液或唾液乾燥然後加入裂 解試劑溶液。對於膠帶+生物流體樣本,狀5_5 ^的 夜或唾液直接加至膠帶的黏著劑之側。對於膠帶剝離 樣本’將2 的人類血液或5 A的唾液加至玻片。當生 物材料乾燥時,以膠帶剝離生物材料。包含皮膚細胞的 膠帶剝離樣本亦從穿過的姉樣本之襯衫領子内側或襯 衫袖口内侧之任一者收集。 099131421 表單編號A0101 第36頁/共54頁 1003014903-0 準備杈斜紋布料樣本(非黑色的粗斜紋布)。使用血液 破採用並風乾之處的5mm打孔而獲得複製4次的血液i ul ★伴隨Tris-C卜緩衝裂解試劑溶液的裂解反應於LySep™ 管杈(Applied Biosystems)中以5〇〇 uL體積而於3 L還原劑(1 μ)以及3 uL 2 0哗/此酵素存在下進行 將&柱於溫度混合器於56 C培養分鐘。依照製造者 建"義的計畫書使用AutoMate Express™套組(Applied iosystems)完成DMA萃取。依照製造者的指導使用 Quantifiler Duo™套組(Applied Bi〇systems)完 成dna定量》依照製造者的指導使用Jderitifiler套組以 進行STR輪廓,並依照製造者的指導於AppHedCm Υ 〇 r 2.5 cm block tape (including biological samples). The blood or saliva is dried and then added to the lysis reagent solution prior to removal by stripping. For tape + biological fluid samples, a night of 5_5 ^ or saliva is added directly to the side of the adhesive on the tape. For tape stripping samples, add 2 human blood or 5 A saliva to the slide. When the biomaterial is dry, the biomaterial is stripped with tape. A tape peeling sample containing skin cells is also collected from either the inside of the shirt collar of the passed sputum sample or the inside of the shirt cuff. 099131421 Form No. A0101 Page 36 of 54 1003014903-0 Prepare a sample of twill fabric (non-black denim). Blood was replicated 4 times using a 5 mm perforation where the blood was broken and air dried. ★ The lysis reaction with the Tris-C Bubuffer lysis reagent solution was applied to the LySepTM tube (Applied Biosystems) in a volume of 5 〇〇uL. The & column was incubated in a temperature mixer at 56 C for 5 minutes in the presence of 3 L reducing agent (1 μ) and 3 uL 2 0 哗 / this enzyme. The DMA extraction was done using the AutoMate ExpressTM kit (Applied iosystems) according to the manufacturer's plan. Use the Quantifiler DuoTM Set (Applied Bi〇systems) to complete the DNA quantification according to the manufacturer's instructions. Use the Jderitifiler kit to perform the STR profile according to the manufacturer's instructions and follow Applicator's instructions to AppHed.

Bl〇systems 3130x1 進行CE分析。. 如同對於粗斜紋布上的血液的描述,分析奴6次複製的口 腔上皮細胞20uL而製備的粗斜紋布料樣本。在黑色粗斜 紋布上的血液為2 uL 3次複製的血液,並依以上對於粗 斜紋布的描述而分析。 ΐι·裂解試劑溶液之製備 製備足夠量的裂解溶液以處理二次複製或三次複製的樣 本數目。經由將220 UL之250-500縫的螫合劑、含有 U w/v的至少一種清潔劑(對其加入〇·5_ι mg/mL酵素 )的?117.9至8.5以及最終濃度是1〇_1〇〇龍之在無 DNase水中新鮮製備的還原劑混合而新鮮配製溶液 。於溫 度範圍大450-70 C下’加上或不加上搖晃而將此裂解混 合物培養—段9〇分鐘至2小時的時間。表格6說明可用於 從固體生物材料與歸_财萃取減的贿溶液, 該固體生物射4與歸性材料包含或被認聽含了含核 表單编號删1 第37頁/共54頁 1003( 201213805 酸之生物樣本。 111. Tris-n-緩衝裂解試劑溶液之製備 製備足夠量的Tris-n-緩衝裂解試劑溶液,以處理二次 複製、三次複製或6次複製的樣本數目。經由將220 μί之 250-1 000 mM的螫合劑、含有0.5 - 3% w/v的至少一種 清潔劑(對其加入0.5-50 mg/mL酵素)的pH 7. 9至8. 5 以及最終濃度是10-1 00 mM之在無DNase水中新鮮製備的 還原劑混合而新鮮配製溶液。將此裂解混合物於温度範 圍大約50-70 ° C下加上或不加上搖晃而培養一段90分鐘 至2小時的時間。 表格6:裂鹏液 配方1 配方Η 配方HI 配方IV 配方V 配方W 配方vn EGTA 250 至 500 mM 0 250 至 500 mM 0 250 至 500 mM 250 至 500 mM 250 至 500 mM EDTA 0 250 至 500 mM 0 250 至 500 mM 0 0 0 DTT 10 至 100 mM 10 至 100 mM 10 至 100 mM 10 至 100 mM 10 至 100 mM 10 至 lOOmM 10 至 100 mM NLS 0.5 至 3%w/v 0.5 至 3 % w/v 0 0 0.5 至 3 % w/v 0 0 去氧膽酸銷 0 0 0.5 至 3 % w/v 0·5 至 3 % w/v 0.5 至 3 % w/v 0 0.5 至 3 % w/v SDS 0 0 0 0 0 0.1至0.5%«^ 0 檸麵納 0 0 0 0 0 50 至 150 mM 0 Triton X 100 0 0 0 0 0 0.1 至 0.3 % v/v 0 NP-40 0 0 0 0 0 0 0-1 至 0.3% 蛋白酶κ 0.5 至 1 mg/mL 0.5 至 1 mg/mL 0.5 Μ 1 mg/mL 0.5 Μ 1 mg/mL 0.5 至 1 mg/mL 0.5 Μ 1 mg/mL 0.5 至 1 表格7 :清洗溶液: 組成分 10 mM Tris-CI, pH 8.0 0.1 mM EDTA 95%乙醇 去氧膽酸鈉(DSD)The CE analysis was performed on the Bl〇systems 3130x1. As described for the blood on the denim, a coarse twill fabric sample prepared by analyzing the oral epithelial cells of 6 copies of the oral cavity was analyzed. The blood on the black denim was 2 uL of 3 replicates of blood and was analyzed as described above for the denim. Preparation of ΐι·Cleavage Reagent Solution A sufficient amount of lysate solution is prepared to treat the number of samples of secondary or tertiary replication. Via 220 liters of 250-500 sewed chelating agent, at least one detergent containing U w / v (added to 〇 5_ι mg / mL of enzyme)? 117.9 to 8.5 and the final concentration is 1〇_1〇〇龙. The freshly prepared reducing agent is mixed in DNase water and freshly prepared. The lysate mixture was incubated at a temperature range of 450-70 C plus or without shaking for a period of 9 minutes to 2 hours. Table 6 illustrates the bribery solution that can be used to extract from solid biomaterials and return-to-financial materials. The solid biofilm 4 and the return material contain or be acknowledged with a nuclear-containing form number. Page 1 of 54 Page 100 of 1003 (201213805 Acid biological sample. 111. Preparation of Tris-n-buffered lysis reagent solution Prepare a sufficient amount of Tris-n-buffered lysing reagent solution to treat the number of samples of secondary replication, triple replication or 6 replications. 220 μί of 250-1 000 mM chelating agent, containing 0.5 - 3% w/v of at least one detergent (to which 0.5-50 mg/mL of enzyme is added), pH 7. 9 to 8.5 and the final concentration is 10-1 00 mM of the freshly prepared reducing agent in DNase-free water is mixed and the solution is freshly prepared. The cleavage mixture is incubated at a temperature range of about 50-70 ° C for a period of 90 minutes to 2 hours with or without shaking. Table 6: Split Pit Formula 1 Formulation 配方 Formula HI Formulation IV Formulation V Formulation W Formulation vn EGTA 250 to 500 mM 0 250 to 500 mM 0 250 to 500 mM 250 to 500 mM 250 to 500 mM EDTA 0 250 to 500 mM 0 250 to 500 mM 0 0 0 DTT 10 to 100 mM 10 to 100 mM 10 to 100 mM 10 to 100 mM 10 to 100 mM 10 to 100 mM 10 to 100 mM NLS 0.5 to 3% w/v 0.5 to 3 % w/v 0 0 0.5 to 3 % w/v 0 0 deoxycholic acid Pin 0 0 0.5 to 3 % w/v 0·5 to 3 % w/v 0.5 to 3 % w/v 0 0.5 to 3 % w/v SDS 0 0 0 0 0 0.1 to 0.5% «^ 0 0 0 0 0 0 50 to 150 mM 0 Triton X 100 0 0 0 0 0 0.1 to 0.3 % v/v 0 NP-40 0 0 0 0 0 0 0-1 to 0.3% Protease κ 0.5 to 1 mg/mL 0.5 To 1 mg/mL 0.5 Μ 1 mg/mL 0.5 Μ 1 mg/mL 0.5 to 1 mg/mL 0.5 Μ 1 mg/mL 0.5 to 1 Table 7: Washing solution: Group composition 10 mM Tris-CI, pH 8.0 0.1 mM EDTA 95% sodium alcohol deoxycholate (DSD)

清洗緩讎ACleaning buffer A

70% 0.5% 清讎讎B 赚濃度 4 mM 0.04 mM 60% 最終體積70% 0.5% Clear B earns 4 mM 0.04 mM 60% Final volume

100 mL 100 mL III.從固體生物樣本萃取核酸 將230 之新鮮配製的裂解溶液加至在2.0 mL螺旋蓋 管中之50 - 200 mg之骨或10 mg之齒粉末。將蓋子關 099131421 表單編號A0101 第38買/共54頁 1003014903-0 201213805 閉並將 $ 子於56 C在Eppendorf® Thermomixer R (100 mL 100 mL III. Extraction of nucleic acids from solid biological samples A freshly prepared lysis solution of 230 was added to 50-200 mg of bone or 10 mg of tooth powder in a 2.0 mL screw cap. Close the lid 099131421 Form No. A0101 No. 38 Buy / Total 54 Pages 1003014903-0 201213805 Closed and placed at 56 C in Eppendorf® Thermomixer R (

Eppendorf North America,Westbury,NY)中、於 Ο 1100 rpm下培養2小時。在培養結束時,將管以1〇, 〇〇〇 X g離心5分鐘’並將澄清的上清液/裂解物(最多21() 口 L·)轉移至含有3〇〇 pL prepFiler™裂解緩衝液之新的 1.5 mL離心管中,並根據製造者之大體積計畫書進行 DNA分離。基本上’將15 uL之PrepFiler™磁性顆粒與 uL 99. 5%異丙醇加入,接著溫和混合。此顆粒是兩 次用PrepFiler™清洗緩衝液(其使用6〇〇 uL以及然後是 300 uL之緩衝液a,接著以30〇 uL Prepiler™清洗 緩衝液B清洗一次)。接著如同冊以及 PrepFiler自動化法醫DNA萃取套組或prepFUer手動套 組使用者指南(P/N 4390932-01 )概威的,將核酸沖提 至5〇 UL之PrepFiler™沖提緩衝液中。 IV.從黏著性材料萃取核酸Incubate at 1100 rpm for 2 hours in Eppendorf North America, Westbury, NY. At the end of the incubation, the tube was centrifuged at 1 〇, 〇〇〇X g for 5 minutes' and the clarified supernatant/lysate (up to 21 () L·) was transferred to a lysis buffer containing 3 〇〇pL prepFilerTM In a new 1.5 mL centrifuge tube, the DNA was separated according to the manufacturer's large volume book. Basically, 15 uL of PrepFilerTM magnetic particles were added with uL 99.5% isopropanol, followed by gentle mixing. This pellet was washed twice with PrepFilerTM Wash Buffer (which used 6 μL of L and then 300 μL of buffer a, followed by 30 μL of PreLerTM Wash Buffer B). Following the book and the PrepFiler Automated Forensic DNA Extraction Kit or the prepFUer Manual Kit User Guide (P/N 4390932-01), the nucleic acid was flushed to 5 〇 UL's PrepFilerTM Extraction Buffer. IV. Extraction of nucleic acids from adhesive materials

將23〇 wL之新鮮配製的裂解溶液加入在丨.5 ‘離心管中 之依上文描述而製備的包含樣本的黏著劑。將蓋子關閉 並將管子於56°C在Eppendorf® Thermom ixer R中、於 750 rpm下培養4〇分鐘。在培養結束時,將内容物轉移 至過濾管柱中(Axygen Scientific, Inc., Union City,CA)。經由將過濾管柱於i6,110 x g離心2分鐘 而將上清液/裂解物自受質分離。將300 pL PrepFiler "*裂解緩衝液加至澄清的上清液/裂解物中,並根據製造 者的計晝書進行DNA分離。 V.從粗斜紋布材料之萃取核酸 將500 之新鮮配製的裂解溶液加入在1.5 mL LySep 099131421 表單編號A0101 第39頁/共54頁 1003014903-0 201213805 管中依同上文描述而製備的包含樣本的生物性(流體) 。將蓋子關閉並將管子於56°C在Eppendorf® Thermo-mixer R中、於750 rpm下培養40分鐘。經由將“以吟 於16, 110 X g離心2分鐘而將上清液/裂解物由受質分離 。將300 UL PrepFiler™裂解緩衝液加至澄清的上清液 /裂解物中,並根據製造者的計畫書進行DNA分離。 VI. DNA分離 如同製造者所描述的(Applied Bi〇systems,Prep_ Filer™法醫DNA萃取套組使用者指南。pn 4390932 Rev. B,(2008)) ’經由按照大量樣本的計畫書(針對 有500 之PrepFiler™裂解緩衝液的使用)而將來自 裂解物的DNA分離。 VII. 人類DNA定量 如同在使用者手冊中所描述的(Applied Biosystems, Quanti f i ler®人類DNA定量套組以及Quantif丨ier®Y 男性人類DNA定量套組。使::用者手冊_。: vpp:N 4344790A 23 〇 wL freshly prepared lysis solution was added to the sample containing adhesive prepared in the 5.5 ‘centrifuge tube as described above. The lid was closed and the tube was incubated at 56 ° C for 4 minutes at 750 rpm in an Eppendorf® Thermometer. At the end of the incubation, the contents were transferred to a filter column (Axygen Scientific, Inc., Union City, CA). The supernatant/lysate was separated from the substrate by centrifuging the filter column at i6, 110 x g for 2 minutes. 300 pL of PrepFiler "* lysis buffer was added to the clarified supernatant/lysate and DNA isolation was performed according to the manufacturer's protocol. V. Extraction of nucleic acids from denim material A freshly prepared lysis solution of 500 is added to a sample containing the sample prepared in the 1.5 mL LySep 099131421 Form No. A0101 Page 39/54 Page 1003014903-0 201213805 tube as described above. Sex (fluid). The lid was closed and the tube was incubated at 56 ° C for 40 minutes at 750 rpm in an Eppendorf® Thermo-mixer R. The supernatant/lysate was separated from the substrate by centrifugation for 2 minutes at ,16, 110 X g. 300 UL PrepFilerTM Lysis Buffer was added to the clarified supernatant/lysate and manufactured according to The program is DNA-separated. VI. DNA isolation is as described by the manufacturer (Applied Bi〇systems, Prep_ FilerTM Forensic DNA Extraction Kit User Guide. pn 4390932 Rev. B, (2008)) DNA from lysates was isolated from a large sample of studies (for the use of 500 PrepFilerTM Lysis Buffer). VII. Human DNA quantification is as described in the user manual (Applied Biosystems, Quanti fi ler® Human DNA Quantitation Kit and Quantif丨ier® Y Male Human DNA Quantitative Set.: :: User's Manual _.: vpp:N 4344790

Rev. B,(2003)),使用2 WL之DNA萃取物,經由 Quant i filer icQuanti filer DUO® 人类員 DNA 定量套 組(Applied Biosystems,Foster City, CA)測定 DNA的量。於7500即時PCR系統進行PCR,並使用7500系 統SDS軟體vl.2.3 (Applied Biosystems,Foster Ci ty,CA )分析資料。 VIII. 短串聯重複序列(STR)分析 使用描述於使用者手冊(Applied Biosystems,AmpF STR®Identi f i ler®PCR擴增套組。使用者手冊。ppN 4323291 Rev. B,(2001))的步驟,將使用 PrepF i ler 099131421 表單編號A0101 第40頁/共54頁 1003014903-0 201213805 TM法醫D N A萃取套組而從生物性樣本獲得的D N A萃取物擴增 而用於Identi f i ler套組分析。如同使用者指南(Applied Biosystems, 《ABI PRISM ② 3100 Genetic Analyzer與ABI PRISM®3100- Avant Genetic Analyzer使用者參考指南》,PN 4335393. RevA, (2002) ’ Appl ied Biosy stems,用於人類鑑定應用的 GeneMapper® ID Software)中的描述,使用 GeneMapper® ID Software v3. 2.1 而於3100或 313Ox 1 Genetic Analyzer (Applied Biosystems) 分析擴增的產物。 雖然本揭露内容係關於各種具體實施例和範例而描述, 可在不背離本發明的精神與範圍下做各種修政。 【圖式簡單說明】 [0006] 第1圖為描述用於由粗斜紋布萃取的重複血液之STR對偶 基因間的色彩間平衡(Intercolor balance (ICB))的 圖》ICB係經由以每一顏色之最大峰值除以最小峰值而計 0 算(異型合子的峰為平均值以及同型合子除以2)。樣本 列於表格6。 【主要元件符號說明】 [0007] ICB 色彩間平衡 099131421 表單編號A0101 第41頁/共54頁 1003014903-0Rev. B, (2003)), using a DNA extract of 2 WL, the amount of DNA was determined via a Quant i filer icQuanti filer DUO® human DNA quantification kit (Applied Biosystems, Foster City, CA). PCR was performed on a 7500 real-time PCR system and analyzed using 7500 System SDS software vl.2.3 (Applied Biosystems, Foster Ci ty, CA). VIII. Short tandem repeat (STR) analysis using the steps described in the User Manual (Applied Biosystems, AmpF STR® Identi Fi ler® PCR Amplification Kit. User Manual. ppN 4323291 Rev. B, (2001)), The DNA extract obtained from the biological sample will be amplified for use in the Identi filer suite analysis using the PrepF iler 099131421 Form No. A0101 page 40/54 page 1003014903-0 201213805TM forensic DNA extraction kit. As in the User Guide (Applied Biosystems, ABI PRISM 2 3100 Genetic Analyzer and ABI PRISM® 3100 - Avant Genetic Analyzer User Reference Guide, PN 4335393. RevA, (2002) 'Appl ied Biosy stems for Human Identification Applications The products described in GeneMapper® ID Software) were analyzed using the GeneMapper® ID Software v3. 2.1 and analyzed at 3100 or 313Ox 1 Genetic Analyzer (Applied Biosystems). While the present disclosure has been described with respect to various specific embodiments and examples, various modifications may be made without departing from the spirit and scope of the invention. BRIEF DESCRIPTION OF THE DRAWINGS [0006] Fig. 1 is a diagram depicting the inter-color balance (Intercolor balance (ICB)) between STR dual genes for repeated blood extracted from denim. The ICB is based on each color. The maximum peak is divided by the minimum peak and counted as 0 (the peak of the heterozygote is the average and the homozygote is divided by 2). The samples are listed in Table 6. [Main component symbol description] [0007] ICB color balance 099131421 Form number A0101 Page 41 of 54 1003014903-0

Claims (1)

201213805 七、申請專利範圍: ^用於省解一固體組織的組合物,該組合物包含一清潔 劑、—螫合劑、一還原劑以及一酵素的其中之-或更多。 2 .如申請專利範圍第1項所述之組合物,其中所述清潔劑係 選自以下的其中之一或更多:N_月桂肌胺酸、去氧膽酸納 jTAB、十二基々_D-麥芽糖甘、壬醯基—甲基麩醯胺 、聚乙二醇P-(l,l,3,3-四曱基丁基)_苯基醚、十二烷 基硫酸鈉以及其結合物。 3 .如申請專利範圍第1項所述之組合物,其中所述螫合劑係 包3以下的其中之一或更多:四醋酸乙二醇(EGTA)、 四醋酸乙二胺(EDTA)與摔檬酸以及其結合物。 4 .如申請專利範圍第!項所述之組合物,其中所述還原劑係 包含以下的其中之一或更多:三(2-緩乙動膦(TCEP) 、—硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 5.如申請專利範圍第W所述之組合物,其中所述酵素係包 T以下的其t之—或更多:半胱天冬酶、騰凝乳蛋白酶、 月蛋白酶、蛋白酶灰、凝血酶、葡萄球菌屬…蛋白酶鏈 黴蛋白酶、木瓜酶 '芽抱桿菌sp. Eu蛋白酶與騰蛋白酶 〇 6 .如申請專利範圍第w所述之組合物,其中所述固體組織 包含核酸。 7.如申請專利範圍第6項所述之組合物,其中所述固體組織 為一鈣化組織、生物材料、黏著性材料或黏著性受質。 8 .如申請專利範圍第7項所述之組合物,其中所述生物材料 係選自骨、軟骨、韌帶、肌腱與齒。 099131421 表單編號A0101 第42頁/共54頁 1003014903-0 201213805 y .如申請專利範圍第7項所述之組合物,其中所述黏著性材 料包含一生物性樣本。 10 .如申請專利範圍第9項所述之組合物,其中所述生物樣本 附著於所述黏著性材料受質。 11 .如申請專利範圍第7項所述之組合物,其中所述黏著性材 料受質係選自口香糖、雪茄屁股、菸蒂、黏著薄膜、黏著 標籤、貼紙、皮膚貼附物、信封、信封封口、郵票、指紋 膠帶剝離以及膠帶、輸送管磁帶與電工膠帶。 12 .如申請專利範圍第11項所述之組合物,其中所述皮膚貼附 ❹ 物係選自以下所組成之群組:電子電極、可轉移的圖騰、 皮膚滲透之化學物質貼片、傷口黏合劑以及傷口照護敷料 〇 13 . —種製造產物的方法,其中所述產物係包含一核酸,該方 法包含: a) 在一溶液中培養一固體; b) 萃取一上清液,其中所述上清液係包含自該固體中萃取 之該核酸。 14 .如申請專利範圍第13項所述之方法,其中所述固體包含所 述核酸。 15 .如申請專利範圍第14項所述之方法,其中所述固體為一生 物材料或者黏著性材料或受質。 16 .如申請專利範圍第15項所述之方法,其中所述生物材料係 選自約化組織、骨、軟骨、韌帶、肌腱以及齒。 17 .如申請專利範圍第15項所述之方法,其中所述黏著性材料 係包含一生物性樣本。 18 .如申請專利範圍第17項所述之方法,其中所述生物性樣本 099131421 表單編號A0101 第43頁/共54頁 1003014903-0 201213805 係般入該黏著性材料受質中。 19 .如申請專利範圍第18項所述之方法,其中所述黏著性材料 \自g it '⑽屁股 '終蒂、黏著薄膜、黏著標藏、 氏皮膚貼附物封、郵票、指紋膠帶剝離以及膠帶 〇 別·如申請專利範圍第19項所述之方法,其中所述皮膚貼附物 係選自以下所組成之群組:電子電極、可轉移的圖騰、皮 膚滲透之化學物質貼片錢傷π照護敷料。 21 ·如申請專利範圍第13項所述之方法,其中所述溶液係包含 以下的其中之一或更多:—清潔劑、一整合劑、一還原劑 以及一酵素。 Μ ·如申請專利範圍第21項所述之方法,其中所述清潔劑係選 自以下的其中之_或更多:卩_月桂肌紐、去氧膽酸納、 CTAB、十二基石_D_麥芽糖甘、壬醯基_Ν_甲基麩醯胺、 聚乙二醇Ρ-(1,1,3,3-四甲基丁基)—苯基醚、十二烷基 硫酸鈉以及其結合物。 - Μ .如申請專利範圍第21項所述之方法,其中所述螫合劑係包 含以下的至少其中之一:四醋醇(EGTA)、四醋 酸乙二胺(EDTA)與檸檬酸。 24 .如申凊專利範圍第21項所述之方法,其中所述還原劑係包 3以下的至少其中之一:三(2_繞乙基)膦(TCEp)、二 硫赤鮮醇(DTE)以及二疏蘇糖醇(j)TT)。 099131421 25 .如申請專利範圍第21項所述之方法,其中所述酵素係包含 以下的其中之一或更多:半胱天冬酶、胰凝乳蛋白酶、胃 蛋白酶、蛋白酶Κ、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴 蛋白酶、木瓜酶、芽孢桿菌sp. E1A蛋白酶與胰蛋白酶以 表單編號A0101 1003014903-0 第44頁/共54頁 201213805 及其結合物。 2 6 . —種製造一產物之方法,其中所述產物係包^ —核酸,該 方法包含以下步驟: (a) 將一樣本以一溶液培養; (b) 搖晃該培養溶液; (c) 萃取一上清液產物,其中所述核酸係位於所述上清液 中〇 27 .如申請專利範圍第26項所述之方法,其中所述樣本係包含 該核酸。 〇 28.如申請專利範圍第27項所述之方法,其争所述樣本為一生 物材料、黏著性材料或受質,或天然或合成之受質。 29 .如申請專利範圍第28項所述之方法,其中所述生物性樣本 係選自骨、軟骨、韌帶、肌腱以及齒。 3〇 .如申請專利範圍第28項所述之方法,其争所述黏著性材料 係包含一生物性樣本。 31 .如申請專利範圍第30項所述之方法,其中所述生物性樣本 _ 係附著於所述黏著性材料。 ◎ 32 .如申請專利範圍第31項所述之方法,其中所述黏著性材料 係選自口香糖、雪茄屁股、菸蒂、黏著薄膜、黏著標籤、 貼紙、皮膚貼附物、信封、郵票、指紋膠帶剝離以及膠帶 〇 33 .如申請專利範圍第32項所述之方法,其中所述皮膚貼附物 係選自以下所組成之群組:電子電極、可轉移的圖騰、皮 膚滲透之化學物質貼片以及傷口照護敷料。 34 .如申請專利範圍第26項所述之方法,其中所述溶液係包含 以下的其中之一或更多:一清潔劑、一螯合劑、一還原劑 099131421 表單編號A0101 第45頁/共54頁 1003014903-0 201213805 以及一酵素。 35 .如申請專利範圍第34項所述之方法,其中所述清潔劑係選 自以下的其中之一或更多:N-月桂肌胺酸、去氧膽酸鈉、 CTAB、十二基0-D-麥芽糖甘、壬醯基-N-甲基麩醯胺、 聚乙二醇p-(l,1,3,3-四甲基丁基)-苯基醚、十二烷基 硫酸鈉以及其結合物。 36 .如申請專利範圍第34項所述之方法,其中所述螫合劑係包 含以下的至少其中之一:四醋酸乙二醇(EGTA)、四醋 酸乙二胺(EDTA)與檸檬酸。 37 .如申請專利範圍第34項所述之方法,其中所述還原劑係包 含以下的至少其中之一:三(2-羧乙基)膦(TCEP)、二 硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 38 . —種製造一產物之方法,其中所述產物係包含一核酸,該 方法包含: (a) 將一固體樣本於一裂解溶液中裂解,以生成含有核酸 之一裂解物; (b) 萃取所述裂解產物,其中所述核酸係位於所述裂解物 中〇 39 .如申請專利範圍第38項所述之方法,其中所述固體樣本係 包含該核酸。 40 .如申請專利範圍第39項所述之方法,其中所述固體為一生 物材料、黏著性材料或受質,或為天然或合成之受質。 41 .如申請專利範圍第40項所述之方法,其中所述生物材料係 選自骨、軟骨、韌帶、肌腱以及齒。 42 .如申請專利範圍第40項所述之方法,其中所述黏著性材料 受質係包含一生物性樣本。 099131421 表單編號A0101 第46頁/共54頁 1003014903-0 201213805 43 .如申請專利範圍第42項所述之方法,’其中所述生物性樣本 係嵌入所述黏著性材料受質中。 44 .如申請專利範圍第43項所述之方法,其中所述黏著性材料 係選自口香糖、雪茄屁股、菸蒂、薄膜、黏著標籤、貼紙 、皮膚貼附物、信封、郵票、以及膠帶。 45 .如申請專利範圍第44項所述之方法,其中所述皮膚貼附物 係選自以下所組成之群組:電子電極、可轉移的圖騰、皮 膚滲透之化學物質貼片以及傷口照護敷料。 46 .如申請專利範圍第38項所述之方法,其中所述裂解溶液係 〇 包含以下的其中之一或更多:一清潔劑、一螫合劑、一還 原劑以及一酵素。 47 .如申請專利範圍第46項所述之方法,其中所述清潔劑係選 自以下的其中之一或更多:N-月桂肌胺酸、去氧膽酸鈉、 CTAB、十二基点-D-麥芽糖甘、壬醯基-N-曱基麩醯胺、 聚乙二醇p-(l, 1,3, 3-四甲基丁基)-苯基醚、十二烷基 硫酸鈉以及其結合物。 48 .如申請專利範圍第46項所述之方法,其中所述螫合劑係包 Ό 含以下的至少其中之一:四醋酸乙二醇(EGTA)、四醋 酸乙二胺(EDTA)與檸檬酸。 49 .如申請專利範圍第46項所述之方法,其中所述還原劑係包 含以下的至少其中之一:三(2-羧乙基)膦(TCEP)、二 硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 50 .如申請專利範圍第46項所述之方法,其中所述酵素係包含 以下的其中之一或更多:半胱天冬酶、胰凝乳蛋白酶、胃 蛋白酶、蛋白酶K、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴 蛋白酶、木瓜酶、芽孢桿菌sp. El A蛋白酶與騰蛋白酶以 099131421 表單編號A0101 第47頁/共54頁 1003014903-0 201213805 及其結合物。 51 . —種從一固體樣本中分離一核酸的方法,該方法包含: (a) 於一裂解溶液中裂解所述固體樣本,以生成包含所述 核酸之一混合物; (b) 將所述混合物離心,其中所述核酸由所述固體樣本中 分離。 52 .如申請專利範圍第51項所述之方法,其中所述固體樣本係 包含該核酸。 53 .如申請專利範圍第52項所述之方法,其中所述固體係一生 物材料、黏著性材料或受質,或一天然或人工受質。 54 .如申請專利範圍第53項所述之方法,其中所述生物材料係 選自骨、軟骨、韌帶、肌腱以及齒。 55 .如申請專利範圍第53項所述之方法,其中所述黏著性材料 係包含一生物性樣本。 56 .如申請專利範圍第55項所述之方法,其中所述生物性樣本 係附著於所述黏著性材料。 57 .如申請專利範圍第56項所述之方法,其中所述黏著性材料 係選自口香糖、雪茄屁股、菸蒂、黏著薄膜、黏著標籤、 貼紙、皮膚貼附物、信封、郵票、指紋膠帶剝離以及膠帶 〇 58 .如申請專利範圍第57項所述之方法,其中所述皮膚貼附物 係選自以下所組成之群組:電子電極、可轉移的圖騰、皮 膚滲透之化學物質貼片以及傷口照護敷料。 59 .如申請專利範圍第51項所述之方法,其中所述裂解溶液係 包含以下的其中之一或更多:一清潔劑、一螫合劑、一還 原劑以及一酵素。 099131421 表單編號A0101 第48頁/共54頁 1003014903-0 201213805 bu .如申請專利範圍第59項所述之方法;其中所述清潔劑係選 自以下的其中之一或更多:N-月桂肌胺酸、去氧膽酸鈉、 CTAB、十二基yS-D-麥芽糖甘、壬醯基-N-甲基麩醯胺、 聚乙二醇p-(l,1,3, 3-四甲基丁基)-苯基醚、十二烷基 硫酸鈉以及其結合物。 61 .如申請專利範圍第59項所述之方法,其中所述螫合劑係包 含以下的至少其中之一:四醋酸乙二醇(EGTA)、四醋 酸乙二胺(EDTA)與檸檬酸。 62 .如申請專利範圍第59項所述之方法,其中所述還原劑係包 〇 含以下的至少其中之一:三(2-羧乙基)膦(TCEP)、二 硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 63 .如申請專利範圍第59項所述之方法,其中所述酵素係包含 以下的其中之一或更多:半胱天冬酶、胰凝乳蛋白酶、胃 蛋白酶、蛋白酶K、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴 蛋白酶、木瓜酶、芽抱桿菌sp. E1A蛋白酶與騰蛋白酶以 及其結合物。 ^ 64 . —種以申請專利範圍第13項所述之方法製造的核酸產物。 Q 65 . —種以申請專利範圍第26項所述之方法製造的核酸產物。 66 . —種以申請專利範圍第38項所述之方法製造的核酸產物。 67 . —種以申請專利範圍第51項所述之方法分離的核酸產物。 68 . —種鑑定的方法,其包含: (a) 於一裂解溶液中一裂解一樣本,以生成包含來自所述 樣本之一核酸的一裂解物; (b) 萃取所述裂解物,其中所述核酸係位於所述裂解物中 9 (C)分析所述核酸; 099131421 表單編號A0101 第49頁/共54頁 1003014903-0 201213805 69 70 71 72 73 74 75 76 099131421 (d)基於核酸分析而鑑定該樣本。 根據申請專利範圍第7 6項所述之方法 指紋膠帶剝離。 如申請專利範圍第51項所述之方法,其中所述裂解溶液俾 包含以下的其中之一或更多:—咖 ' 原劑以及一酵素。 如申請專利範圍第59項所述之方法,其中所述清潔劑係選 自Μ下的其中之—或更多:N_月桂肌胺酸、去氧膽酸納、 CTAB、十二基终麥芽糖甘、壬醯基.甲基麩醯胺、 聚乙二醇P-(1,1,3, 3-四甲基丁基)_苯躺、十二燒基 硫酸鈉以及其結合物。 , 如申請專利範圍第59項所述之方法,其中所述螫合劑係包 3以下的至少其中之四醋酸乙二醇(肅八)、四醋 酸乙二胺(EDTA)與檸檬酸。 如申請專利範圍第59項所述之方法,其中所述還原劑係包 含以下的至少其中之一:三(2_齡基)鱗(TCEp)、二 硫赤鮮醇(DTE)以及二硫蘇糖鳟㈣打)。 如申請專利範圍第59項所述之方法,其中所述酵素係包含 以下的其中之—或更多:半胱天冬酶、胰凝乳蛋白酶胃 蛋白酶、蛋白酶κ、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴 蛋白酶、木瓜酶、芽孢桿菌sp. EU蛋白酶與胰蛋白酶以 及其結合物。 如申請專利範圍第69項所述之方法,其進_步包含將該指 紋與一指紋收集庫比對。 —種用於從一固體樣本中萃取核酸的套組,該套組包含: 一種裂解緩衝液。 表單編號Α0101 其中所述樣本為 螫合劑 還 第50頁/共54頁 10030l· 201213805 77 . 78 . 79 . Ο 80 . 81 . Ο 82 . 83 . 84 . 如申請專利範圍第76項所述之套組,其中所述裂解緩衝液 係包含以下的其中之一或更多:一清潔劑、一螫合劑、一 還原劑以及一酵素。 如申請專利範圍第76項所述之套組,其中所述清潔劑係選 自以下的其中之一或更多:Ν-月桂肌胺酸、去氧膽酸鈉、 CTAB、十二基/S-D-麥芽糖甘、壬醯基-Ν-甲基麩醯胺、 聚乙二醇ρ-(1,1,3, 3-四甲基丁基)-苯基醚、十二烷基 硫酸鈉以及其結合物。 如申請專利範圍第76項所述之套組,其中所述螫合劑係包 含以下的至少其中之一:四醋酸乙二醇(EGTA)、四醋 酸乙二胺(EDTA)與擰檬酸。 如申請專利範圍第76項所述之套組,其中所述還原劑係包 含以下的至少其中之一:三(2-羧乙基)膦(TCEP)、二 硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 如申請專利範圍第76項所述之套組,其中所述酵素係包含 以下的其中之一或更多:半胱天冬酶、胰凝乳蛋白酶、胃 蛋白酶、蛋白酶K、凝血酶、葡萄球菌屬V8蛋白酶、鏈黴 蛋白酶、木瓜酶、芽孢桿菌sp._ E__1__A蛋白酶與胰蛋白酶以 及其結合物。 如申請專利範圍第76項所述之套組,其中所述固體樣本係 選自一生物材料以及一黏著性材料。 如申請專利範圍第82項所述之套組,其中所述生物材料係 選自骨、軟骨、韌帶、肌腱以及齒。 如申請專利範圍第83項所述之套組,其中所述黏著性材料 係選自口香糖、雪茄屁股、菸蒂、黏著薄膜、黏著標籤、 貼紙、皮膚貼附物、信封、郵票、指紋膠帶剝離以及膠帶 099131421 表單編號A0101 第51頁/共54頁 1003014903-0 201213805 85 .如申請專利範圍第84項所述之套組,其中所述皮膚貼附物 係選自以下所組成之組群:電子電極、可轉移的圖騰、皮 膚滲透之化學物質貼片以及傷口照護敷料。 86 .如申請專利範圍第76項所述之套組,其隨選地包含:包含 一聚合物和清潔劑的一溶液;以及可被磁性吸引的顆粒。 87 .如申請專利範圍第86項所述之套組,其中所述聚合物係包 含以下的其中之一或更多:葡聚醣,纖維素,纖維素衍 生物、可溶性澱粉、糊精、纖維糊精、聚乙二醇、肝素、 肝醣以及其結合物。 88 .如申請專利範圍第86項所述之套組,其中所述清潔劑係包 含以下的其中之一或更多:N-月桂肌胺酸、去氧膽酸鈉、 CTAB、十二基沒-D-麥芽糖甘、壬醯基-N-曱基麩醯胺、 聚乙二醇p-(l,1,3, 3-四甲基丁基)-苯基醚、十二烷基 硫酸鈉以及其結合物。 89 .如申請專利範圍第86項所述之套組,其中所述可被磁性吸 引的顆粒係包含被葡聚醣包裹的磁性奈米顆粒。 90 .如申請專利範圍第86項所述之套組,其中所述之隨選溶液 的所有内容物皆位在一個容器中。 91 .如申請專利範圍第86項所述之套組,其進一步包含一磁性 裝置。 92 .如申請專利範圍第86項所述之套組,其進一步包含一清洗 溶液。 93 .如申請專利範圍第1項所述之組合物,其進一步包含選自 KC1 ' NaCl、MgCl、MnCl2之一鹽類。 94 . 一種用於裂解在一粗斜紋布上之生物性樣本的組合物,該 099131421 表單編號A0101 第52頁/共54頁 1003014903-0 201213805 組合物包含以下的其中之一或更多:一清潔劑、一螫合劑 、一鹽類、一還原劑以及一酵素。 9 5 .如申請專利範圍第9 4項所述之組合物,其中所述清潔劑係 選自以下的其中之一或更多:N-月桂肌胺酸、去氧膽酸鈉 、CTAB、十二基麥芽糖甘、壬醯基-N-甲基麩醯胺 、聚乙二醇p-(l,1,3, 3-四甲基丁基)-苯基醚 '十二烷 基硫酸鈉以及其結合物。 96 . 〇 97 . 如申請專利範圍第94項所述之組合物,其中所述螫合劑係 包含以下的其中之一或更多:四醋酸乙二醇(EGTA)、 四醋酸乙二胺(EDTA)與檸檬酸以及其結合物。 如申請專利範圍第94項所述之組合物,其中所述還原劑係 包含以下的其中之一或更多:三(2-羧乙基)膦(TCEP) 、二硫赤鮮醇(DTE)以及二硫蘇糖醇(DTT)。 98 .如申請專利範圍第94項所述之組合物,其中所述酵素係包 含以下的其中之一或更多:半胱天冬酶、胰凝乳蛋白酶、 胃蛋白酶、蛋白酶K、凝血酶、葡萄球菌屬Ύ8蛋白酶、鏈 黴蛋白酶、木瓜酶、芽孢桿菌sp. E1A蛋白酶與胰蛋白酶 〇 99 .如申請專利範圍第94項所述之組合物,其中的粗斜紋布包 含該核酸。 100 . —種包含如申請專利範圍第94項所述之一裂解缓衝液的套 099131421 表單編號A0101 第53頁/共54頁 1003014903-0201213805 VII. Patent application scope: ^ A composition for solving a solid tissue, the composition comprising a detergent, a chelating agent, a reducing agent and one or more of an enzyme. 2. The composition of claim 1, wherein the cleaning agent is selected from one or more of the following: N_lauric myosin, sodium dehydrocholate jTAB, dodecyl hydrazine _D-maltose, thiol-methyl branamide, polyethylene glycol P-(l,l,3,3-tetradecylbutyl)-phenyl ether, sodium lauryl sulfate and Conjugate. 3. The composition of claim 1, wherein the chelating agent is one or more of the following: ethylene glycol tetraacetate (EGTA), ethylenediaminetetraacetate (EDTA), and The citric acid and its combination. 4. If you apply for a patent scope! The composition according to the above, wherein the reducing agent comprises one or more of the following: tris(2-sulfate phosphine (TCEP), sulfur red alcohol (DTE), and dithiothreitol ( DTT) 5. The composition of claim W, wherein the enzyme is T or less than T: caspase, chymotrypsin, lunar protease, protease ash , thrombin, staphylococcus, protease, protease, papain, bacillus, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium, bacterium The composition of claim 6, wherein the solid tissue is a calcified tissue, a biomaterial, an adhesive material or an adhesive substrate. 8. The composition of claim 7 The composition of the biological material is selected from the group consisting of bone, cartilage, ligament, tendon, and tooth. 099131421 Form No. A0101 Page 42 of 54 1003014903-0 201213805 y. The composition of claim 7, wherein The adhesive material comprises The composition of claim 9, wherein the biological sample is attached to the adhesive material. The composition of claim 7, wherein the composition of claim 7 The adhesive material is selected from the group consisting of chewing gum, cigar butt, cigarette butts, adhesive films, adhesive labels, stickers, skin patches, envelopes, envelope seals, stamps, fingerprint tape peeling and tape, duct tape and electrical tape. 12. The composition of claim 11, wherein the dermal patch is selected from the group consisting of: an electronic electrode, a transferable totem, a skin infiltrated chemical patch, a wound A method of making a product, wherein the product comprises a nucleic acid, the method comprising: a) culturing a solid in a solution; b) extracting a supernatant, wherein The supernatant contains the nucleic acid extracted from the solid. The method of claim 13, wherein the solid comprises the nucleic acid. The method of claim 14, wherein the solid is a raw material or an adhesive material or a substrate. The method of claim 15, wherein the biological material is selected from the group consisting of a reduced tissue, a bone, a cartilage, a ligament, a tendon, and a tooth. The method of claim 15, wherein the adhesive material comprises a biological sample. 18. The method of claim 17, wherein the biological sample 099131421 Form No. A0101 Page 43 of 54 1003014903-0 201213805 is incorporated into the adhesive material. 19. The method of claim 18, wherein the adhesive material is removed from the git' (10) buttocks, the adhesive film, the adhesive label, the skin patch, the stamp, and the fingerprint tape. The method of claim 19, wherein the skin patch is selected from the group consisting of: an electronic electrode, a transferable totem, and a skin infiltrated chemical patch. Injury π care dressing. The method of claim 13, wherein the solution comprises one or more of the following: a detergent, an integrator, a reducing agent, and an enzyme. The method of claim 21, wherein the cleaning agent is selected from the group consisting of 卩 or more: 卩 _ laurel muscle, sodium deoxycholate, CTAB, twelfth stone _D _ maltose, thiol_Ν_methyl branamide, polyethylene glycol oxime-(1,1,3,3-tetramethylbutyl)-phenyl ether, sodium lauryl sulfate and Conjugate. The method of claim 21, wherein the chelating agent comprises at least one of the following: tetraacetic alcohol (EGTA), ethylenediamine tetraacetate (EDTA), and citric acid. The method of claim 21, wherein the reducing agent is at least one of the following: tris(2_cycloethyl)phosphine (TCEp), dithioerythritol (DTE) And di-threitol (j) TT). 099131421. The method of claim 21, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin, pepsin, protease, thrombin, Staphylococcus V8 protease, pronase, papain, Bacillus sp. E1A protease and trypsin are listed in the form No. A0101 1003014903-0, page 44/54, 201213805 and combinations thereof. A method of producing a product, wherein the product is a nucleic acid, the method comprising the steps of: (a) culturing the same solution as a solution; (b) shaking the culture solution; (c) extracting A supernatant product, wherein the nucleic acid is located in the supernatant. The method of claim 26, wherein the sample comprises the nucleic acid. 〇 28. The method of claim 27, wherein the sample is a biomaterial, an adhesive material or a substrate, or a natural or synthetic substrate. The method of claim 28, wherein the biological sample is selected from the group consisting of bone, cartilage, ligament, tendon, and tooth. 3. The method of claim 28, wherein the adhesive material comprises a biological sample. The method of claim 30, wherein the biological sample is attached to the adhesive material. The method of claim 31, wherein the adhesive material is selected from the group consisting of chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, sticker, skin patch, envelope, stamp, fingerprint tape The method of claim 32, wherein the skin patch is selected from the group consisting of an electronic electrode, a transferable totem, and a skin infiltrated chemical patch. And wound care dressings. The method of claim 26, wherein the solution comprises one or more of the following: a cleaning agent, a chelating agent, a reducing agent 099131421, Form No. A0101, page 45/54 Page 1003014903-0 201213805 and an enzyme. The method of claim 34, wherein the detergent is selected from one or more of the following: N-lauric acid, sodium deoxycholate, CTAB, dodecaine -D-maltose, thiol-N-methyl branamide, polyethylene glycol p-(l,1,3,3-tetramethylbutyl)-phenyl ether, sodium lauryl sulfate And its combination. The method of claim 34, wherein the chelating agent comprises at least one of the following: ethylene glycol tetraacetate (EGTA), ethylenediamine tetraacetate (EDTA), and citric acid. 37. The method of claim 34, wherein the reducing agent comprises at least one of tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE), and Dithiothreitol (DTT). 38. A method of making a product, wherein the product comprises a nucleic acid, the method comprising: (a) lysing a solid sample in a lysis solution to produce a lysate comprising one of the nucleic acids; (b) extracting The cleavage product, wherein the nucleic acid system is located in the lysate, the method of claim 38, wherein the solid sample comprises the nucleic acid. 40. The method of claim 39, wherein the solid is a biomaterial, an adhesive material or a substrate, or a natural or synthetic substrate. The method of claim 40, wherein the biological material is selected from the group consisting of bone, cartilage, ligament, tendon, and tooth. 42. The method of claim 40, wherein the adhesive material substrate comprises a biological sample. 099131421 Form No. A0101 Page 46 of 54 1003014903-0 201213805 43. The method of claim 42, wherein the biological sample is embedded in the adhesive material substrate. 44. The method of claim 43, wherein the adhesive material is selected from the group consisting of chewing gum, cigar butt, cigarette butts, films, adhesive labels, stickers, skin patches, envelopes, stamps, and tapes. The method of claim 44, wherein the skin patch is selected from the group consisting of an electronic electrode, a transferable totem, a skin infiltrated chemical patch, and a wound care dressing. . 46. The method of claim 38, wherein the lysis solution system comprises one or more of the following: a cleaning agent, a chelating agent, a reducing agent, and an enzyme. 47. The method of claim 46, wherein the detergent is selected from one or more of the following: N-lauric myosin, sodium deoxycholate, CTAB, twelve base points - D-maltose, thiol-N-mercapto branamine, polyethylene glycol p-(l, 1,3,3-tetramethylbutyl)-phenyl ether, sodium lauryl sulfate and Its combination. The method of claim 46, wherein the chelating agent comprises at least one of the following: ethylene glycol tetraacetate (EGTA), ethylenediaminetetraacetate (EDTA), and citric acid. . The method of claim 46, wherein the reducing agent comprises at least one of tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE), and Dithiothreitol (DTT). 50. The method of claim 46, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin, pepsin, proteinase K, thrombin, grapes Cocinobacterium V8 protease, pronase, papain, Bacillus sp. El A protease and TGase are 099131421 Form No. A0101 Page 47 / Total 54 Page 1003014903-0 201213805 and combinations thereof. 51. A method of isolating a nucleic acid from a solid sample, the method comprising: (a) lysing the solid sample in a lysis solution to produce a mixture comprising the nucleic acid; (b) the mixture Centrifugation wherein the nucleic acid is separated from the solid sample. The method of claim 51, wherein the solid sample comprises the nucleic acid. 53. The method of claim 52, wherein the solid is a biomaterial, an adhesive material or a substrate, or a natural or artificial substrate. 54. The method of claim 53, wherein the biological material is selected from the group consisting of bone, cartilage, ligament, tendon, and teeth. The method of claim 53, wherein the adhesive material comprises a biological sample. The method of claim 55, wherein the biological sample is attached to the adhesive material. 57. The method of claim 56, wherein the adhesive material is selected from the group consisting of chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, sticker, skin patch, envelope, stamp, and fingerprint tape stripping. The method of claim 57, wherein the skin patch is selected from the group consisting of an electronic electrode, a transferable totem, a skin infiltrated chemical patch, and Wound care dressing. The method of claim 51, wherein the lysing solution comprises one or more of the following: a cleaning agent, a chelating agent, a reducing agent, and an enzyme. The method of claim 59, wherein the cleaning agent is selected from one or more of the following: N-lauric muscles, the method of claim 59, wherein Amino acid, sodium deoxycholate, CTAB, dodecyl yS-D-maltose, thiol-N-methyl branamide, polyethylene glycol p-(l,1,3,3-tetra Butyl)-phenyl ether, sodium lauryl sulfate and combinations thereof. 61. The method of claim 59, wherein the chelating agent comprises at least one of the following: ethylene glycol tetraacetate (EGTA), ethylenediamine tetraacetate (EDTA), and citric acid. 62. The method of claim 59, wherein the reducing agent comprises at least one of: tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE) And dithiothreitol (DTT). 63. The method of claim 59, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin, pepsin, proteinase K, thrombin, grapes Coccus V8 protease, pronase, papain, Bacillus sp. sp. E1A protease and TGase and combinations thereof. ^ 64 . A nucleic acid product produced by the method described in claim 13 of the patent application. Q 65. A nucleic acid product produced by the method described in claim 26 of the patent application. 66. A nucleic acid product produced by the method described in claim 38. 67. A nucleic acid product isolated by the method described in claim 51. 68. A method of identification comprising: (a) lysing a cleavage solution in a lysis solution to produce a lysate comprising nucleic acids from one of said samples; (b) extracting said lysate, wherein The nucleic acid is located in the lysate 9 (C) to analyze the nucleic acid; 099131421 Form No. A0101 Page 49 / Total 54 Page 1003014903-0 201213805 69 70 71 72 73 74 75 76 099131421 (d) Identification based on nucleic acid analysis The sample. The fingerprint tape was peeled off according to the method described in claim 76. The method of claim 51, wherein the lysis solution 包含 comprises one or more of the following: a coffee agent and an enzyme. The method of claim 59, wherein the cleaning agent is selected from the group consisting of - or more: N_lauric acid, sodium deoxycholate, CTAB, twelfth terminal maltose Gan, thiol. methyl branamide, polyethylene glycol P-(1,1,3,3-tetramethylbutyl)-benzoic acid, sodium lauryl sulfate and combinations thereof. The method of claim 59, wherein the chelating agent is at least four of ethylene glycol (E.g.), ethylenediaminetetraacetate (EDTA) and citric acid below the package 3. The method of claim 59, wherein the reducing agent comprises at least one of the following: a tris(2-aged) scale (TCEp), a dithioerythritol (DTE), and a disulfide. Glycocalyx (four) hit). The method of claim 59, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin pepsin, protease kappa, thrombin, Staphylococcus V8 Protease, pronase, papain, Bacillus sp. EU protease and trypsin and combinations thereof. The method of claim 69, wherein the step of comparing comprises directing the fingerprint with a fingerprint collection library. A kit for extracting nucleic acids from a solid sample, the kit comprising: a lysis buffer. Form No. Α0101, wherein the sample is a chelating agent, also 50th page/54 pages 10030l·201213805 77.78.79. Ο80.81. Ο82.83.84. Set according to claim 76 The group, wherein the lysis buffer comprises one or more of the following: a detergent, a chelating agent, a reducing agent, and an enzyme. The kit of claim 76, wherein the cleaning agent is one or more selected from the group consisting of strontium-lauric acid, sodium deoxycholate, CTAB, and twelfth/SD. - maltose, thiol-oxime-methyl branamide, polyethylene glycol ρ-(1,1,3,3-tetramethylbutyl)-phenyl ether, sodium lauryl sulfate and Conjugate. The kit of claim 76, wherein the chelating agent comprises at least one of the following: ethylene glycol tetraacetate (EGTA), ethylenediamine tetraacetate (EDTA), and citric acid. The kit of claim 76, wherein the reducing agent comprises at least one of: tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE), and Thiothelitol (DTT). The kit of claim 76, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin, pepsin, proteinase K, thrombin, staphylococcus It belongs to V8 protease, pronase, papain, Bacillus sp._E__1__A protease and trypsin and combinations thereof. The kit of claim 76, wherein the solid sample is selected from the group consisting of a biomaterial and an adhesive material. The kit of claim 82, wherein the biomaterial is selected from the group consisting of bone, cartilage, ligament, tendon, and teeth. The kit of claim 83, wherein the adhesive material is selected from the group consisting of chewing gum, cigar butt, cigarette butt, adhesive film, adhesive label, sticker, skin patch, envelope, stamp, fingerprint tape stripping, and the like. Tape 099131421 Form No. A0101 Page 51 of 54 1003014903-0 201213805 85. The kit of claim 84, wherein the skin patch is selected from the group consisting of: an electronic electrode , transferable totems, skin penetration chemical patches, and wound care dressings. 86. The kit of claim 76, which optionally comprises: a solution comprising a polymer and a cleaning agent; and particles that are magnetically attracted. 87. The kit of claim 86, wherein the polymer comprises one or more of the following: dextran, cellulose, cellulose derivatives, soluble starch, dextrin, fiber Dextrin, polyethylene glycol, heparin, glycogen, and combinations thereof. 88. The kit of claim 86, wherein the detergent comprises one or more of the following: N-lauric myosin, sodium deoxycholate, CTAB, dodecaine -D-maltose, thiol-N-mercapto branamine, polyethylene glycol p-(l,1,3,3-tetramethylbutyl)-phenyl ether, sodium lauryl sulfate And its combination. 89. The kit of claim 86, wherein the magnetically permeable particles comprise magnetic nanoparticles coated with dextran. 90. The kit of claim 86, wherein all of the contents of the on-demand solution are in a single container. 91. The kit of claim 86, further comprising a magnetic device. 92. The kit of claim 86, further comprising a cleaning solution. 93. The composition of claim 1, further comprising a salt selected from the group consisting of KCl's NaCl, MgCl, and MnCl2. 94. A composition for lysing a biological sample on a denim, the 099131421 Form No. A0101 Page 52 of 54 1003014903-0 201213805 The composition comprises one or more of the following: a cleaning agent , a chelating agent, a salt, a reducing agent and an enzyme. The composition of claim 94, wherein the detergent is selected from one or more of the following: N-lauric myosin, sodium deoxycholate, CTAB, ten Di-male maltose, thiol-N-methyl branamide, polyethylene glycol p-(l,1,3,3-tetramethylbutyl)-phenyl ether sodium lauryl sulfate and Its combination. 96. The composition of claim 94, wherein the chelating agent comprises one or more of the following: ethylene glycol tetraacetate (EGTA), ethylenediamine tetraacetate (EDTA) ) with citric acid and its combination. The composition of claim 94, wherein the reducing agent comprises one or more of the following: tris(2-carboxyethyl)phosphine (TCEP), dithioerythritol (DTE) And dithiothreitol (DTT). 98. The composition of claim 94, wherein the enzyme comprises one or more of the following: caspase, chymotrypsin, pepsin, proteinase K, thrombin, Staphylococcus genus 8 protease, pronase, papain, bacillus sp. E1A protease and trypsin 〇 99. The composition of claim 94, wherein the denim comprises the nucleic acid. 100. A sleeve containing a lysis buffer as described in claim 94 of the patent application. 099131421 Form No. A0101 Page 53 of 54 1003014903-0
TW99131421A 2010-09-16 2010-09-16 Lysis buffers for extracting nucleic acids TW201213805A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW99131421A TW201213805A (en) 2010-09-16 2010-09-16 Lysis buffers for extracting nucleic acids

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW99131421A TW201213805A (en) 2010-09-16 2010-09-16 Lysis buffers for extracting nucleic acids

Publications (1)

Publication Number Publication Date
TW201213805A true TW201213805A (en) 2012-04-01

Family

ID=46786339

Family Applications (1)

Application Number Title Priority Date Filing Date
TW99131421A TW201213805A (en) 2010-09-16 2010-09-16 Lysis buffers for extracting nucleic acids

Country Status (1)

Country Link
TW (1) TW201213805A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3904532A1 (en) * 2020-04-28 2021-11-03 CapitalBio Corporation Nucleic acid extraction composition, reagent and kit containing the same and use thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3904532A1 (en) * 2020-04-28 2021-11-03 CapitalBio Corporation Nucleic acid extraction composition, reagent and kit containing the same and use thereof

Similar Documents

Publication Publication Date Title
US11820978B2 (en) Lysis buffers for extracting nucleic acids
Butler Advanced topics in forensic DNA typing: methodology
Van Oorschot et al. Forensic trace DNA: a review
Alaeddini Forensic implications of PCR inhibition—a review
Girish et al. Dental DNA fingerprinting in identification of human remains
McNevin et al. Short tandem repeat (STR) genotyping of keratinised hair: Part 1. Review of current status and knowledge gaps
Danaher et al. Facile semi-automated forensic body fluid identification by multiplex solution hybridization of NanoString® barcode probes to specific mRNA targets
Castella et al. Forensic evaluation of the QIAshredder/QIAamp DNA extraction procedure
Kumar et al. Effects of latent fingerprint development reagents on subsequent forensic DNA typing: A review
CN104531673B (en) Method and kit for DNA extractions
CN112029900A (en) Rapid nucleic acid detection method and detection system for novel coronavirus
Fridez et al. PCR DNA typing of stamps: evaluation of the DNA extraction
Nakanishi et al. Effects of environmental conditions to which nails are exposed on DNA analysis of them
Hytinen et al. Methods for Obtaining High-Quality Touch DNA from a Nonporous Surface after Latent Fingerprint Collection.
Prakash et al. Bioterrorism: Challenges and considerations
TW201213805A (en) Lysis buffers for extracting nucleic acids
US20240200053A1 (en) Lysis buffers for extracting nucleic acids
Chaudhary et al. DNA in forensic odontology: New phase in dental analysis
Kitpipit et al. Low-cost direct PCR for aged and processed wildlife sample analysis
Mehta et al. Human induced pluripotent stem cells generated from STING-associated vasculopathy with onset in infancy (SAVI) patients with a heterozygous mutation in the STING gene
JP2023521803A (en) Product for detection of viral nucleic acid and method for detection thereof
Oleiwi Experimental approaches to improving trace DNA recovery from developed fingerprints
CN113943730B (en) Primer composition and application thereof
Shrivastava et al. Biological sources of DNA: the target materials for forensic DNA typing
CN107119044B (en) Wiping reagent for contact DNA transfer on carrier